Kazuaki Takabe MD, PhD, FACS

Kazuaki Takabe
MD, PhD, FACS

Professor of Oncology, Alfiero Foundation Chair and Clinical Chief of Breast Surgery for Roswell Park

Jacobs School of Medicine & Biomedical Sciences

Surg Roswell Park Cancer Institute
Elm & Carlton St.
Buffalo, New York 14263
Phone: 716-845-5540
Fax: 716-845-5705
kazuakit@buffalo.edu

View map

Overview Research Publications Activities Latest News

Education and Training:

Virginia Commonwealth University (2008)
University of California San Diego (2006)
University of California San Diego (2002)
PhD, Yokohama City University Graduate School of Medicine (1999)
Niigata University Hospital (1995)
MD, Niigata University School of Medicine (1992)

Employment:

Chair and Clinical Chief of Breast Surgery, Surgery, Roswell Park Cancer Institute Jacobs School of Medicine & Biomedical Sciences (2016-present)
Tenured, Surgery, Virginia Commonwealth University (2016-present)
Tenured Professor of Oncology, Roswell Park Cancer Institute (2016-present)
Visiting Professor, Tokyo Medical University School of Medicine (2016-present)
Visiting Professor, Yokohama City University School of Medicine (2016-present)
Affiliate Professor, School of Medicine - Surgery, Tokyo Medical University School of Medicine
Affiliate Professor, Surgery, Yokohama City University School of Medicine Yokohama City University School of Medicine
Alfiero Foundation Chair and Clinical Chief of Breast Surgery
Division of Surgical Oncology, Dept. of Surgery UB, Jacobs School of Medicine & Biomedical Sciences
Associate Professor, Surgery, Virginia Commonwealth University (2013–2016)
Assistant Professor, Biochemistry & Molecular Biology, Virginia Commonwealth University (2008–2013)

See all (1 more)

Awards and Honors:

First Place of G. Watson James Research Abstract Award (2016)
Outstanding Speaker, Cancer Biology (2015)
First Prize Winner of Basic Science category Cancer Paper Competition (2015)
Presenter at the Surgical Forum of Annual Surgical Congress (2014)
Scholarship for 2014 Geisel Leadership Course (2014)
The Best Basic Research Award (2014)
Second Prize Winner - Basic Science Research (2014)
Second Place winner of Bigger-Lehman Award (2014)
Third Prize Winner of Poster Presentation Competition (2014)
First Prize Winner of Basic Science category Cancer Paper Competition (2014)
James D. Popp Summer Research Fellowship (I.A. Woelfel) (2014)
2013 SERLC Oral Presentation Travel Award, 48th Annual Southeastern Regional Lipid Conference (M. Nagahashi) (2013)
Clinical Research Award, VCU Institute for Women’s Health (2013)
Elizabeth Fries Young Investigator Award, VCU Institute for Women’s Health, Women’s Health Research Day (A. Yamada) (2013)
James D. Popp Summer Research Fellowship (S. DeMasi) (2013)
16th Yujin Memorial Young Investigator Award (2012)
Winner - VCU Dep of Surgery Resident Paper Competition (B.J. Adams) (2012)
Second Place winner of Bigger-Lehman Award (2012)
David M. Hume Memorial Resident Presentation (2012)
Elizabeth Fries Young Investigator Award, VCU Institute for Women’s Health, 8th Annual VCU Women’s Health Research Day (M. Nagahashi) (2012)
Basic Science Award, VCU Institute for Women’s Health (2012)
First Prize Winner of Basic Science category Cancer Paper Competition (2012)
First Place - Clinical & Translational Research Category (2012)
Excellence in Cancer Research Award (First Place) (2011)
Excellence in Research Award in Targeted Therapies category (2011)
2011 ICAMS/LCRD Research Retreat – Outstanding Presentation (2011)
2011 ICAMS/LCRD Research Retreat – Outstanding Presentation (2011)
First Prize Winner - Basic Science Research (2011)
Winners - VCU Dep of Surgery Resident Paper Competition (2011)
Spring Semester Travel Award, VCU Postdoctoral Association (2011)
Patients’ Choice Award (2011)
Best Basic and Translational Research Poster (2011)
Fellow of American College of Surgeons (2010)
First Prize Winner - Basic Science Research (2010)
Photo Contest Winner (2009)
First Prize - Residents Papers Competition (2009)
Patients’ Choice award (2009)
First Prize - Cancer Basic Research Paper Competition (2009)
Finalist Best Poster Contest at 62nd Annual Cancer Symposium (2009)
2nd Prize Winner - Basic Science Research (2008)
One of America’s Top Surgeons (2007)
First Prize Winner of Resident Paper Competition (2007)
First Prize Winner of Resident Paper Competition (2006)
9th Yujin Memorial Young Investigator Award (2005)
Surgical Forum Presenter (2004)
Surgical Forum Presenter (2003)
Third Prize, 342th Sankei Paper Competition “My Medical Reform” (2003)
Prize Winner (2003)
First Prize Winner (2002)
Who's Who in America (2002)
President’s Choice Poster Presentation (1999)
Third prize (1992)

Grants and Sponsored Research:

December 2015–November 2020
Role of Tumor &/or Host Sphingosine-1-Phosphate in Hem-&lymphangiogenesis
Susan G. Komen
Role: Principal Investigator
$180,000
December 2015–November 2020
Bile Acid and Sphingosine -1- phosphate Receptor-mediated Signaling in Cholestasis
NIH/National Institute of Digestive Disease and Kidney
Role: Co-Investigator
$37,475
February 2012–June 2017
Regulation of hepatic SphK2 by bile acids: effects on lipid metabolism
NIH/National Institute of Digestive Disease and Kidney
Role: Co-Investigator
$11,661
July 2012–April 2017
Sphingosine-1-phosphate in breast cancer progression and lymphangiogenesis
NIH/National Cancer Institute TME
Role: Principal Investigator
$1,008,785
–May 2015
Manipulation of Sphingosine-1-phosphate signaling as a novel approach for enhancing immune checkpoint targeted therapy for breast cancer lung metastasis
Massey Cancer Center
Role: Principal Investigator
$3,000
July 2011–April 2015
Regulation of caspase 9 RNA splicing in NSCLC cancer
NIH/National Cancer Institute
Role: Co-Investigator
$4,600
–March 2015
The role of Sphingosine-1-phosphate in the breast cancer lung metastasis and prognosis
The James D. Popp Student Research Fund
Role: Contributor
$5,000
February 2014–January 2015
Role of mitochondrial Stat3 in breast cancer growth and progression
Massey Cancer Center
Role: Co-Investigator
$100,000
November 2013–June 2014
The S1P signaling pathway as a novel therapeutic target for advanced colorectal cancer
NIH/T32 Postdoctoral Training Award
Role: Consultant
April 2012–April 2014
The role of sphingosine-1-phosphate in obesity-mediated breast cancer progression
Japan Society for the Promotion of Science
Role: Contributor
$100,000
–April 2014
Targeting S1P signaling for pancreatic cancer peritoneal carcinomatosis
Massey Cancer Center
Role: Principal Investigator
$5,000
–March 2014
The role of sphingosine-1-phosphate in colon cancer peritoneal carcinomatosis
The James D. Popp Student Research Fund
Role: Contributor
$5,000
–January 2014
Ceramide kinase, UVRAG, and ceramide-1-phosphate: The triumvirate of breast cancer metastasis?
VCU Massey Cancer Center
Role: Co-Investigator
–July 2013
Targeting the S1P Axis and Development of a Novel Therapy for Obesity-Related Triple Negative Breast Cancer
Department of Defense
Role: Contributor
$7,215
–January 2013
Targeting the sphingosine-1-phosphate axis: Potential new therapy for obesity-related breast cancer
VCU Massey Cancer Center
Role: Co-Principal Investigator
October 2009–September 2012
Sphingosine Kinase 1 as a New Target for Systemic Therapy against Breast Cancer Development and Characterization of Novel Sphingosine Kinase 1 Inhibitor
Susan G. Komen for the Cure; Career Catalyst Research Grant
Role: Principal Investigator
$450,000
April 2012–July 2012
Sphingosine-1-phosphate in breast cancer progression and lymphangiogenesis
VCU School of Medicine
Role: Principal Investigator
$50,000
January 2008–July 2012
Role of ABC Transporters in Sphingosine Kinase Induced Tumorigenicity of Breast Cancer
NIH/National Institute of Child Health and Human Development
Role: Contributor
$500,000
April 2009–March 2011
Role of Sphingosine-1-phosphate in cancer
Sumitomo Life Social Welfare Services Foundation
Role: Contributor
$18,750
July 2007–June 2008
Signaling in Tissue Injury and Repair
NIH/National Institute of General Medical Sciences
Role: Contributor
$54,002
July 2006–June 2008
Neoadjuvant Chemotherapy for Breast Cancer, Correlating Response with Gene Expression Profiles and MTA 1 Expression.
V-Foundation
Role: Co-Investigator
April 2001–June 2001
The role of activin in liver regeneration
Gail I. Zucherman Foundation Funds
Role: Principal Investigator
$20,000
September 1997–July 2000
Research Fellowship at the Salk Institute for Biological Studies
Yoshida Scholarship Foundation
Role: Principal Investigator
$110,000
March 2014
Role of mitochondrial Stat3 in breast cancer growth and progression
Massey Cancer Center
Role: Co-Investigator
$27,000

See all (14 more)

Journal Articles:

Abe K, Kuribayashi T, Takabe K, Nakamura S. (2020) Implications of back-and-forth motion and powerful propulsion for spirochetal invasion. Sci Rep (Aug), 10(1): 13937-13937.
Tokumaru Y, Oshi M, Katsuta E, Yan L, Huang JL, Nagahashi M, Matsuhashi N, Futamura M, Yoshida K, Takabe K. (2020) Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation. Int J Mol Sci (Aug), 21(16).
Tsuchida J, Nagahashi M, Nakajima M, Katsuta E, Rashid OM, Qi Q, Yan L, Okuda S, Takabe K, Wakai T. (2020) Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer. J Surg Res (Aug), 256: 645-656.
Dhakal A, Antony Thomas R, Levine EG, Brufsky A, Takabe K, Hanna MG, Attwood K, Miller A, Khoury T, Early AP, Soniwala S, O'Connor T, Opyrchal M. (2020) Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib. Breast Cancer (Auckl) (Jul), 14: 1178223420-1178223420.
Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Nagahashi M, Matsuyama R, Endo I, Takabe K. (2020) The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2- Breast Cancer. Cells (Jul), 9(7).
Takahashi H, Katsuta E, Yan L, Tokumaru Y, Katz MHG, Takabe K. (2020) Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis. Cancers (Basel) (Jul), 12(8).
Asaoka M, Patnaik SK, Zhang F, Ishikawa T, Takabe K. (2020) Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response. Breast Cancer Res Treat (Jun), 181(2): 309-322.
Katsuta E, Rashid OM, Takabe K. (2020) Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models. Hum Cell (Jun).
Gandhi S, Elkhanany A, Oshi M, Dai T, Opyrchal M, Mohammadpour H, Repasky EA, Takabe K. (2020) Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer. Int J Mol Sci (Jun), 21(13).
Takahashi H, Oshi M, Asaoka M, Yan L, Endo I, Takabe K. (2020) Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers. Ann Surg Oncol (May).
Oshi M, Katsuta E, Yan L, Ebos JML, Rashid OM, Matsuyama R, Endo I, Takabe K. (2020) A Novel 4-Gene Score to Predict Survival, Distant Metastasis and Response to Neoadjuvant Therapy in Breast Cancer. Cancers (Basel) (May), 12(5).
Takahashi H, Oshi M, Asaoka M, Ishikawa T, Endo I, Takabe K. (2020) ASO Author Reflections: Transitioning From Morphology to Transcriptomics in Capturing Tumor Biology. Ann Surg Oncol (May).
Takahashi H, Kawaguchi T, Yan L, Peng X, Qi Q, Morris LGT, Chan TA, Tsung A, Otsuji E, Takabe K. (2020) Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma. Cancers (Basel) (May), 12(5).
Katsuta E, Rashid OM, Takabe K. (2020) Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma. Int J Mol Sci (May), 21(11).
Tokumaru Y, Asaoka M, Oshi M, Katsuta E, Yan L, Narayanan S, Sugito N, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. (2020) High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer. Int J Mol Sci (May), 21(9).
Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Matsuyama R, Endo I, Takabe K. (2020) G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer. Int J Mol Sci (Apr), 21(8).
Tokumaru Y, Takabe K, Yoshida K, Akao Y. (2020) Effects of MIR143 on rat sarcoma signaling networks in solid tumors: A brief overview. Cancer Sci (Apr), 111(4): 1076-1083.
Tokumaru Y, Katsuta E, Oshi M, Sporn JC, Yan L, Le L, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. (2020) High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer. Int J Mol Sci (Apr), 21(9).
Murakami K, Obata Y, Sekikawa A, Ueda H, Izuo N, Awano T, Takabe K, Shimizu T, Irie K. (2020) An RNA aptamer with potent affinity for a toxic dimer of amyloid Î²42 has potential utility for histochemical studies of Alzheimer's disease. J Biol Chem (Apr), 295(15): 4870-4880.
Tokumaru Y, Oshi M, Katsuta E, Yan L, Satyananda V, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. (2020) KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival. Am J Cancer Res (Mar), 10(3): 897-907.
Hait NC, Maiti A, Xu P, Qi Q, Kawaguchi T, Okano M, Takabe K, Yan L, Luo C. (2020) Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate. FASEB J (Mar), 34(3): 4293-4310.
Oshi M, Okano M, Maiti A, Rashid OM, Saito K, Kono K, Matsuyama R, Endo I, Takabe K. (2020) Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies. Cancers (Basel) (Feb), 12(2).
Aoki M, Kondo A, Matsunaga N, Honda A, Okubo Y, Takabe K, Ogawa R. (2020) The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars. J Immunol Res (Jan), 2020: 7057195-7057195.
Okano M, Oshi M, Butash A, Okano I, Saito K, Kawaguchi T, Nagahashi M, Kono K, Ohtake T, Takabe K. (2020) Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts. J Mammary Gland Biol Neoplasia (Jan), 25(1): 27-36.
Takahashi H, Asaoka M, Yan L, Rashid OM, Oshi M, Ishikawa T, Nagahashi M, Takabe K. (2020) Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate. Sci Rep (Jan), 10(1): 1852-1852.
Asaoka M, Narui K, Suganuma N, Chishima T, Yamada A, Sugae S, Kawai S, Uenaka N, Teraoka S, Miyahara K, Kawate T, Sato E, Nagao T, Matsubara Y, Gandhi S, Takabe K, Ishikawa T. (2019) Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy. Eur J Surg Oncol (Dec), 45(12): 2289-2294.
Katsuta E, Yan L, Takeshita T, McDonald KA, Dasgupta S, Opyrchal M, Takabe K. (2019) High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer. Int J Mol Sci (Dec), 21(1).
Takeshita T, Yan L, Asaoka M, Rashid O, Takabe K. (2019) Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor. Sci Rep (Nov), 9(1): 16942-16942.
Takeshita T, Asaoka M, Katsuta E, Photiadis SJ, Narayanan S, Yan L, Takabe K. (2019) High expression of polo-like kinase 1 is associated with TP53 inactivation, DNA repair deficiency, and worse prognosis in ER positive Her2 negative breast cancer. Am J Transl Res (Oct), 11(10): 6507-6521.
Hoki T, Katsuta E, Yan L, Takabe K, Ito F. (2019) Low DMT1 Expression Associates With IncreasedÂ Oxidative Phosphorylation and EarlyÂ Recurrence in Hepatocellular Carcinoma. J Surg Res (Jan), 234: 343-352.
Katsuta E, Qi Q, Peng X, Hochwald SN, Yan L, Takabe K. (2019) Pancreatic adenocarcinomas with mature blood vessels have better overall survival. Sci Rep (Jan), 9(1): 1310-1310.
Kawaguchi T, Yan L, Qi Q, Peng X, Edge SB, Young J, Yao S, Liu S, Otsuji E, Takabe K. (2018) Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Ann Surg Oncol (Dec), 25(13): 4037-4046.
Dhakal A, Matthews CM, Levine EG, Salerno KE, Zhang F, Takabe K, Early AP, Edge SB, O'Connor T, Khoury T, Young JS, Opyrchal M. (2018) Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment. Clin Breast Cancer (Dec), 18(6): 1401-1405.
Gabriel EM, Fisher DT, Evans S, Takabe K, Skitzki JJ. (2018) Intravital microscopy in the study of the tumor microenvironment: from bench to human application. Oncotarget (Apr), 9(28): 20165-20178.
Maiti A, Takabe K, Hait NC. (2017) Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival. Cell Signal (Apr), 32: 85-92.
Strode M, Khoury T, Mangieri C, Takabe K. (2017) Update on the diagnosis and management of malignant phyllodes tumors of the breast. Breast (Mar), 33: 91-96.
Ramanathan R, Olex AL, Dozmorov M, Bear HD, Fernandez LJ, Takabe K. (2017) Angiopoietin pathway gene expression associated with poor breast cancer survival. Breast Cancer Res Treat (Feb), 162(1): 191-198.
Wang Y, Aoki H, Yang J, Peng K, Liu R, Li X, Qiang X, Sun L, Gurley EC, Lai G, Zhang L, Liang G, Nagahashi M, Takabe K, Pandak WM, Hylemon PB, Zhou H. (2017) The role of S1PR2 in bile acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice. Hepatology (Jan).
Takabe K. (2016) Twitter as a survey tool for real-time unbiased snapshots of personal sentiment in population level. J Surg Res (Dec), 206(2): 543-544.
Nagahashi M, Yamada A, Aoyagi T, Allegood J, Wakai T, Spiegel S, Takabe K. (2016) Sphingosine-1-phosphate in the lymphatic fluid determined by novel methods. Heliyon (Dec), 2(12): 00219-00219.
Nagahashi M, Wakai T, Shimada Y, Ichikawa H, Kameyama H, Kobayashi T, Sakata J, Yagi R, Sato N, Kitagawa Y, Uetake H, Yoshida K, Oki E, Kudo SE, Izutsu H, Kodama K, Nakada M, Tse J, Russell M, Heyer J, Powers W, Sun R, Ring JE, Takabe K, Protopopov A, Ling Y, Okuda S, Lyle S. (2016) Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine. Genome Med (Dec), 8(1): 136-136.
Aoki H, Aoki M, Yang J, Katsuta E, Mukhopadhyay P, Ramanathan R, Woelfel IA, Wang X, Spiegel S, Zhou H, Takabe K. (2016) Murine model of long-term obstructive jaundice. J Surg Res (Nov), 206(1): 118-125.
Aoki H, Aoki M, Katsuta E, Ramanathan R, Idowu MO, Spiegel S, Takabe K. (2016) Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis. J Surg Res (Oct), 205(2): 510-517.
Tsuchida J, Nagahashi M, Nakajima M, Moro K, Tatsuda K, Ramanathan R, Takabe K, Wakai T. (2016) Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis. J Surg Res (Sep), 205(1): 85-94.
Rashid OM, Maurente D, Takabe K. (2016) A Systematic Approach to Preclinical Trials in Metastatic Breast Cancer. Chemotherapy (Los Angel) (Sep), 5(3).
Nagahashi M, Matsuda Y, Moro K, Tsuchida J, Soma D, Hirose Y, Kobayashi T, Kosugi S, Takabe K, Komatsu M, Wakai T. (2016) DNA damage response and sphingolipid signaling in liver diseases. Surg Today (Sep), 46(9): 995-1005.
Nagahashi M, Yuza K, Hirose Y, Nakajima M, Ramanathan R, Hait NC, Hylemon PB, Zhou H, Takabe K, Wakai T. (2016) The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases. J Lipid Res (Sep), 57(9): 1636-1643.
Woelfel IA, Takabe K. (2016) Successful intravenous catheterization by medical students. J Surg Res (Aug), 204(2): 351-360.
Katsuta E, DeMasi SC, Terracina KP, Spiegel S, Phan GQ, Bear HD, Takabe K. (2016) Modified breast cancer model for preclinical immunotherapy studies. J Surg Res (Aug), 204(2): 467-474.
Yamada A, Narui K, Sugae S, Shimizu D, Takabe K, Ichikawa Y, Ishikawa T, Endo I. (2016) Operation with less adjuvant therapy for elderly breast cancer. J Surg Res (Aug), 204(2): 410-417.
Huang WC, Liang J, Nagahashi M, Avni D, Yamada A, Maceyka M, Wolen AR, Kordula T, Milstien S, Takabe K, Oravecz T, Spiegel S. (2016) Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans. FASEB J (Aug), 30(8): 2945-2958.
Nagahashi M, Tsuchida J, Moro K, Hasegawa M, Tatsuda K, Woelfel IA, Takabe K, Wakai T. (2016) High levels of sphingolipids in human breast cancer. J Surg Res (Aug), 204(2): 435-444.
Moro K, Nagahashi M, Ramanathan R, Takabe K, Wakai T. (2016) Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World J Clin Cases (Jul), 4(7): 155-164.
Nagahashi M, Yamada A, Miyazaki H, Allegood JC, Tsuchida J, Aoyagi T, Huang WC, Terracina KP, Adams BJ, Rashid OM, Milstien S, Wakai T, Spiegel S, Takabe K. (2016) Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods. J Mammary Gland Biol Neoplasia (Jun), 21(1-2): 9-17.
Aoki M, Aoki H, Ramanathan R, Hait NC, Takabe K. (2016) Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential. Mediators Inflamm (Feb), 2016: 8606878-8606878.
Donoviel MS, Hait NC, Ramachandran S, Maceyka M, Takabe K, Milstien S, Oravecz T, Spiegel S. (2015) Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases. FASEB J (Dec), 29(12): 5018-5028.
Terracina KP, Aoyagi T, Huang WC, Nagahashi M, Yamada A, Aoki K, Takabe K. (2015) Development of a metastatic murine colon cancer model. J Surg Res (Nov), 199(1): 106-114.
Mukhopadhyay P, Ramanathan R, Takabe K. (2015) S1P promotes breast cancer progression by angiogenesis and lymphangiogenesis. Breast Cancer Manag (Oct), 4(5): 241-244.
Tsuchida J, Nagahashi M, Rashid OM, Takabe K, Wakai T. (2015) At what age should screening mammography be recommended for Asian women?. Cancer Med (Jul), 4(7): 1136-1144.
Hait NC, Avni D, Yamada A, Nagahashi M, Aoyagi T, Aoki H, Dumur CI, Zelenko Z, Gallagher EJ, Leroith D, Milstien S, Takabe K, Spiegel S. (2015) The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERÎ± expression and enhances hormonal therapy for breast cancer. Oncogenesis (Jun), 4: 156-156.
Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K. (2015) Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol (Apr), 7(4): 17-29.
Nagahashi M, Takabe K, Liu R, Peng K, Wang X, Wang Y, Hait NC, Wang X, Allegood JC, Yamada A, Aoyagi T, Liang J, Pandak WM, Spiegel S, Hylemon PB, Zhou H. (2015) Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology (Apr), 61(4): 1216-1226.
Rashid OM, Takabe K. (2015) Animal models for exploring the pharmacokinetics of breast cancer therapies. Expert Opin Drug Metab Toxicol (Feb), 11(2): 221-230.
Ishikawa T, Ichikawa Y, Shimizu D, Sasaki T, Tanabe M, Chishima T, Takabe K, Endo I. (2014) The role of HER-2 in Breast Cancer. J Surg Sci (Dec), 2(1): 4-9.
Ishikawa T, Sasaki T, Tanabe M, Narui K, Kida K, Shimada K, Shimizu D, Yamada A, Morita S, Oba MS, Kawachi K, Nozawa A, Ichikawa Y, Takabe K, Endo I. (2014) The Pathological Response to Anthracycline is Associated with Topoisomerase IIÎ± Gene Amplification in the HER2 Breast Cancer Subset. J Surg Sci (Dec), 2(1): 10-12.
Raza A, Takabe K, Wolfe LG, Lockhart CG, Kim RH. (2014) Outcomes of Hybrid Video Assisted Thoracoscopic Surgery for Pulmonary Metastasectomy. J Surg Sci (Dec), 2(1): 18-24.
Rashid OM, Nagahashi M, Ramachandran S, Dumur C, Schaum J, Yamada A, Terracina KP, Milstien S, Spiegel S, Takabe K. (2014) An improved syngeneic orthotopic murine model of human breast cancer progression. Breast Cancer Res Treat (Oct), 147(3): 501-512.
Raza A, Huang WC, Takabe K. (2014) Advances in the management of peritoneal mesothelioma. World J Gastroenterol (Sep), 20(33): 11700-11712.
Takabe K, Spiegel S. (2014) Export of sphingosine-1-phosphate and cancer progression. J Lipid Res (Sep), 55(9): 1839-1846.
Aoyagi T, Terracina KP, Raza A, Takabe K. (2014) Current treatment options for colon cancer peritoneal carcinomatosis. World J Gastroenterol (Sep), 20(35): 12493-12500.
Nagahashi M, Takabe K, Terracina KP, Soma D, Hirose Y, Kobayashi T, Matsuda Y, Wakai T. (2014) Sphingosine-1-phosphate transporters as targets for cancer therapy. Biomed Res Int (Jul), 2014: 651727-651727.
Takabe K. (2014) How to best utilize the Clinical Congress of ACS. Japan Chapter of American College of Surgeons 2014 (Apr), 6(4).
Harikumar KB, Yester JW, Surace MJ, Oyeniran C, Price MM, Huang WC, Hait NC, Allegood JC, Yamada A, Kong X, Lazear HM, Bhardwaj R, Takabe K, Diamond MS, Luo C, Milstien S, Spiegel S, Kordula T. (2014) K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5. Nat Immunol (Mar), 15(3): 231-238.
Rashid OM, Takabe K. (2014) Does removal of the primary tumor in metastatic breast cancer improve survival?. J Womens Health (Larchmt) (Feb), 23(2): 184-188.
Arora TK, Terracina KP, Soong J, Idowu MO, Takabe K. (2014) Primary and secondary angiosarcoma of the breast. Gland Surg (Feb), 3(1): 28-34.
Nagahashi M, Hait NC, Maceyka M, Avni D, Takabe K, Milstien S, Spiegel S. (2014) Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. Adv Biol Regul (Jan), 54: 112-120.
Nagahashi M, Aoyagi T, Yamada A, Rashid OM, Adams BJ, Takabe K. (2013) Intestinal Co-infection of Tuberculosis and CMV can Cause Massive Lower GI Bleeding in a Patient with HIV. J Surg Sci (Dec), 1(1): 12-15.
Rashid OM, Nagahashi M, Ramachandran S, Dumur CI, Schaum JC, Yamada A, Aoyagi T, Milstien S, Spiegel S, Takabe K. (2013) Is tail vein injection a relevant breast cancer lung metastasis model?. J Thorac Dis (Aug), 5(4): 385-392.
Trebska-McGowan K, Terracina KP, Takabe K. (2013) Update on the surgical management of Paget's disease. Gland Surg (Aug), 2(3).
Rashid OM, Nagahashi M, Ramachandran S, Graham L, Yamada A, Spiegel S, Bear HD, Takabe K. (2013) Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. Surgery (Jun), 153(6): 771-778.
Miyazaki H, Takabe K, Yeudall WA. (2013) Chemokines, chemokine receptors and the gastrointestinal system. World J Gastroenterol (May), 19(19): 2847-2863.
Rashid OM, Nagahashi M, Takabe K. (2013) Minimally invasive colostomy revision for palliation of large stomal prolapse and an adherent sliding peristomal hernia. Am Surg (Apr), 79(4): 167-168.
Rashid OM, Cassano AD, Takabe K. (2013) Thymic neoplasm: a rare disease with a complex clinical presentation. J Thorac Dis (Apr), 5(2): 173-183.
Nagahashi M, Kim EY, Yamada A, Ramachandran S, Allegood JC, Hait NC, Maceyka M, Milstien S, Takabe K, Spiegel S. (2013) Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network. FASEB J (Mar), 27(3): 1001-1011.
Yamada A, Ishikawa T, Ota I, Kimura M, Shimizu D, Tanabe M, Chishima T, Sasaki T, Ichikawa Y, Morita S, Yoshiura K, Takabe K, Endo I. (2013) High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival. Breast Cancer Res Treat (Feb), 137(3): 773-782.
Huang WC, Nagahashi M, Terracina KP, Takabe K. (2013) Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis. Biomolecules (Jan), 3(3).
Liang J, Nagahashi M, Kim EY, Harikumar KB, Yamada A, Huang WC, Hait NC, Allegood JC, Price MM, Avni D, Takabe K, Kordula T, Milstien S, Spiegel S. (2013) Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell (Jan), 23(1): 107-120.
Rashid AM, Williams C, Noble J, Rashid OM, Takabe K, Anand RJ. (2012) Pneumothorax, an underappreciated complication with an airway exchange catheter. J Thorac Dis (Dec), 4(6): 659-662.
Rashid OM, Ku JK, Nagahashi M, Yamada A, Takabe K. (2012) Inverted Meckel's diverticulum as a cause of occult lower gastrointestinal hemorrhage. World J Gastroenterol (Nov), 18(42): 6155-6159.
Yamada A, Takabe K. (2012) Should we examine sentinel lymph nodes during the operation?. Gland Surg (Nov), 1(3): 161-163.
Aoyagi T, Nagahashi M, Yamada A, Takabe K. (2012) The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. Lymphat Res Biol (Sep), 10(3): 97-106.
Rashid OM, Takabe K. (2012) The evolution of the role of surgery in the management of breast cancer lung metastasis. J Thorac Dis (Aug), 4(4): 420-424.
Takabe K, Yamada A, Rashid OM, Adams BJ, Huang WC, Aoyagi T, Nagahashi M. (2012) Twofer anti-vascular therapy targeting sphingosine-1-phosphate for breast cancer. Gland Surg (Aug), 1(2): 80-83.
Adams BJ, Goldberg S, Massey HD, Takabe K. (2012) A cause of unbearably painful breast, diffuse dermal angiomatosis. Gland Surg (Aug), 1(2).
Rashid OM, Takabe K. (2012) Are video-assisted thoracoscopic surgery (VATS) and robotic video-assisted thoracic surgery (RVATS) for pulmonary resection ready for prime time?. J Thorac Dis (Aug), 4(4): 341-342.
Seitelman E, Arellano JJ, Takabe K, Barrett L, Faust G, Angus LD. (2012) Chylothorax after blunt trauma. J Thorac Dis (Jun), 4(3): 327-330.
Rashid OM, Nagahashi M, Takabe K. (2012) Management of massive soft tissue defects: The use of INTEGRAÂ® artificial skin after necrotizing soft tissue infection of the chest. J Thorac Dis (Jun), 4(3): 331-335.
Rashid OM, Takabe K. (2012) Sentinel Lymph Node Biopsy for Breast Cancer: Our Technique and Future Directions in Lymph Node Staging. J Nucl Med Radiat Ther (May), 2012(S2).
Stevenson CE, Nagahashi M, Ramachandran S, Yamada A, Bear HD, Takabe K. (2012) Bevacizumab and breast cancer: what does the future hold?. Future Oncol (Apr), 8(4): 403-414.
Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, Zhao R, Milstien S, Zhou H, Spiegel S, Takabe K. (2012) Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res (Feb), 72(3): 726-735.
Studer E, Zhou X, Zhao R, Wang Y, Takabe K, Nagahashi M, Pandak WM, Dent P, Spiegel S, Shi R, Xu W, Liu X, Bohdan P, Zhang L, Zhou H, Hylemon PB. (2012) Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology (Jan), 55(1): 267-276.
Stevenson CE, Takabe K, Nagahashi M, Milstien S, Spiegel S. (2011) Targeting sphingosine-1-phosphate in hematologic malignancies. Anticancer Agents Med Chem (Nov), 11(9): 794-798.
Seitelman E, Donenfeld P, Kay K, Takabe K, Andaz S, Fox S. (2011) Successful treatment of primary pulmonary melanoma. J Thorac Dis (Sep), 3(3): 207-208.
Takabe K. (2011) Is T790M mutation the key in development of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)?. J Thorac Dis (Mar), 3(1): 1-3.
Kim RH, Takabe K, Lockhart CG. (2010) Outcomes of a hybrid technique for video-assisted thoracoscopic surgery (VATS) pulmonary resection in a community setting. J Thorac Dis (Dec), 2(4): 210-214.
Ramachandran S, Shida D, Nagahashi M, Fang X, Milstien S, Takabe K, Spiegel S. (2010) Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription. FEBS Lett (Sep), 584(18): 4077-4082.
Nagahashi M, Ramachandran S, Rashid OM, Takabe K. (2010) Lymphangiogenesis: a new player in cancer progression. World J Gastroenterol (Aug), 16(32): 4003-4012.
Kim RH, Takabe K. (2010) Methods of esophagogastric anastomoses following esophagectomy for cancer: A systematic review. J Surg Oncol (May), 101(6): 527-533.
Takabe K, Kim RH, Allegood JC, Mitra P, Ramachandran S, Nagahashi M, Harikumar KB, Hait NC, Milstien S, Spiegel S. (2010) Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem (Apr), 285(14): 10477-10486.
Kim RH, Takabe K, Lockhart CG. (2010) A hybrid technique: video-assisted thoracoscopic surgery (VATS) pulmonary resections for community-based surgeons. Surg Endosc (Mar), 24(3): 700-704.
Takabe K, Hatakeyama K. (2009) Computed tomography is useful for preoperative workup of gastric rupture caused by blunt trauma. Surg Today (Dec), 39(12): 1109-1109.
Kim RH, Takabe K, Milstien S, Spiegel S. (2009) Export and functions of sphingosine-1-phosphate. Biochim Biophys Acta (Jul), 1791(7): 692-696.
Shida D, Fang X, Kordula T, Takabe K, LÃ©pine S, Alvarez SE, Milstien S, Spiegel S. (2008) Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res (Aug), 68(16): 6569-6577.
Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S. (2008) Targeting SphK1 as a new strategy against cancer. Curr Drug Targets (Aug), 9(8): 662-673.
Takabe K, Paugh SW, Milstien S, Spiegel S. (2008) "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev (Jun), 60(2): 181-195.
Takabe K. (2007) Hernia sac laparoscopy under spinal anesthesia for evaluation of reduced incarcerated inguinal hernia. J Gastrointest Surg (Aug), 11(8): 1081-1082.
Dobke M, Chung C, Takabe K. (2006) Facial aesthetic preferences among Asian women: are all oriental Asians the same?. Aesthetic Plast Surg (May), 30(3): 342-347.
Takabe K, Greenberg JI, Blair SL. (2006) Giant peritoneal loose bodies. J Gastrointest Surg (Mar), 10(3): 465-468.
Takabe K, Al-Refaie W, Chin B, Chu PK, Baird SM, Blair SL. (2005) Can large B-cell lymphoma mimic cystic lesions of the spleen?. Int J Gastrointest Cancer (Jan), 35(1): 83-88.
Takabe K, Holman PR, Herbst KD, Glass CA, Bouvet M. (2004) Successful perioperative management of factor X deficiency associated with primary amyloidosis. J Gastrointest Surg (Mar), 8(3): 358-362.
Takabe K, Wang L, Leal AM, Macconell LA, Wiater E, Tomiya T, Ohno A, Verma IM, Vale W. (2003) Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology (Nov), 38(5): 1107-1115.
Mori Y, Nishii H, Takabe K, Shinozaki H, Matsumoto N, Suzuki K, Tanabe H, Watanabe A, Ochiai K, Tanaka T. (2003) Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary. Gynecol Oncol (Aug), 90(2): 338-341.
Leal AM, Takabe K, Wang L, Donaldson CJ, MacConell LA, Bilezikjian LM, Verma IM, Vale W. (2002) Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo. Endocrinology (Mar), 143(3): 964-969.
Takabe K, Ohtani T, Muto I, Takano Y, Miyauchi T, Kato H, Sekido H, Ohki S, Hatakeyama K, Shimada H. (2000) Computed tomography (CT) findings of gastric rupture after blunt trauma. Hepatogastroenterology (May), 47(33): 901-903.
Takabe K, Lebrun JJ, Nagashima Y, Ichikawa Y, Mitsuhashi M, Momiyama N, Ishikawa T, Shimada H, Vale WW. (1999) Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation. Endocrinology (Jul), 140(7): 3125-3132.
Wang L, Takabe K, Bidlingmaier SM, Ill CR, Verma IM. (1999) Sustained correction of bleeding disorder in hemophilia B mice by gene therapy. Proc Natl Acad Sci U S A (Mar), 96(7): 3906-3910.
Lebrun JJ, Takabe K, Chen Y, Vale W. (1999) Roles of pathway-specific and inhibitory Smads in activin receptor signaling. Mol Endocrinol (Jan), 13(1): 15-23.
Takabe K, Nakatani Y, Kanaya H, Takimoto A, Endo I, Sekido H, Shimada H. (1997) Segmental pericholangial fibrosis: a peculiar benign fibrosing disease at the hepatic hilum. J Pediatr Surg (Dec), 32(12): 1767-1770.
Tatebe S, Ohzeki H, Miyamura H, Hayashi J, Hiratsuka M, Sunami E, Takabe K, Eguchi S. (1994) Carney's complex in association with right atrial myxoma. Ann Thorac Surg (Aug), 58(2): 561-562.

See all (119 more)

Abstracts:

Katsuta E., DeMasi S., Terracina KP., Aoki H., Aoki M., Mukhopadhyay P., Spiegel S., Takabe K. (2016) How Fast Can the Immune Response Eliminate Murine Cancer Cells from a Different Background?. Annals of Surgical Oncology, (Feb) 85
Aoki H., Aoki M., Katsuta E., Fernandez LJ., Mukhopadhyay P., Barnett C., Spiegel S., Takabe K. (2016) Conjugated Bile Acid Promote the Proliferation of Pancreatic Cancer via Sphingosine 1-Phosphate Receptor. Annals of Surgical Oncology, (Feb) 401
Aoki H., Aoki M., Mukhopadhyay P., Barnett C., Spiegel S., Takabe K. (2016) Inflammation Induced by Sphingosine Kinase of the Host Aggravates Pancreatic Cancer Peritoneal Carcinomatosis. Annals of Surgical Oncology, (Feb)
Tsuchida J., Nagahashi M., Moro K., Tatsuda K, Koyama Y., Takabe K, Wakai T. (2016) Obesity increases the lipid mediator, sphingosine-1-phosphate in the tumor and tumor microenvironment, and promotes tumor progression. Cancer Research, (Feb) 1-3
Nagahashi M., Tsuchida J., Moro K., Tatsuda K., Koyama Y., Takabe K, Wakai T. (2016) Sphingosine-1-phosphate signaling promotes metastatic niches and lung metastasis in obesity-related breast cancer. Cancer Research, (Feb)
Takabe K, Nagahashi M., Spiegel S. (2016) Sphingosine-1-phosphate Signaling Targeted by FTY720 Suppress Obesity-related Breast Cancer Progression, Metastasis and Improve Survival. Annals of Surgical Oncology, (Feb)
Hait NC., Avni D., Yamada A., Milstien S., Takabe K, Spiegel S. (2015) FTY720-P is a potent inhibitor of class I histone deacetylases that enhances histone acetylation, reactivates ERa expression, and increases hormonal therapeutic sensitivity of breast cancer. Cancer Research, (Apr) 112
Aoyagi T., Avni D., Nagahashi M., Yamada A., Terracina KP., Huang WC., Aoki K., Spiegel S., Matsubara H., Takabe K. (2015) FTY720 suppressed CT26 murine colon cancer peritoneal carcinomatosis progression by decreasing tumor associated macrophages and TNF-alpha. Cancer Research, (Apr) 407
Woelfel IA., Terracina KP., Lima S., Oyeniran C., Mukhopadhyay P., Aoki H., Avni D., Hait NC., Newton J., Wu X., Yamamoto H., Spiegel S., Takabe K. (2015) Gene silencing of SphK1 with nanoparticles as an innovative approach against cancer progression. Journal of Surgial Research, (Feb)
Fernandez LJ., Wolen AR., Olex AL., Dozmorov MG., Fenstermacher DA., Takabe K. (2015) Is patient derived xenograft model appropriate for colon cancer preclinical drug development?. Annals of Surgical Oncology, (Feb) 120
Terracina KP., Aoyagi T., Huang W., Yamada A., Nagahashi M., Takabe K. (2015) Improvements to a Murine Colon Cancer Model for Cancer Progression and the Tumor Microenvironment. Journal of Surgical Research, (Feb)
Fernandez L., Huang WC., Terracina KP., Yamada A., Aoyagi T., Nagahashi M., Spiegel S., Takabe K. (2015) S1P Forms a Feed-Forward Loop with the Ang2 and VEGF-C Pathways in Lymphangiogenesis. Journal of Surgical Research, (Feb)
Aoki H., Raza A., Mukhopadhyay P., Terracina KP., Barnette CC., Spiegel S., Takabe K. (2015) Role of sphingosine kinase 1 of the host in the progression of pancreatic cancer peritoneal carcinomatosis. Journal of Surgical Research, (Feb)
Fernandez L., Huang WC., Terracina KP, Nagahashi M., Yamada A., Aoyagi T., Spiegel S., Takabe K. (2015) Role of Sphingosine-1-Phosphate in Inflammation-Induced Lymphangiogenesis. Journal of Surgical Research, (Feb)
Terracina KP., Aoyagi T., Huang W., Yamada A., Nagahashi M., Takabe K. (2015) Modified Orthotopic Murine Colon Cancer Cell Implantation Method that Mimics Clinical Cancer Progression. Annals of Surgical Oncology, (Feb) 151
Meier J., Raza A., Yamada A., Dai Y., Chen S., Grant S., Takabe K, Larner A. (2014) 107 STAT3 interacts with Cyclophilin D in cancer cells to regulate the mitochondrial permeability transition pore. Cytokine, (Nov)
Yamada A., Nagahashi M., Aoyagi T., Huang WC., Terracina KP., Allegood JC., Lima S., Milstien S., Spiegel S., Kida K., Ishikawa T., Endo I., Takabe K. (2014) Activated SphK1 and export of S1P via ABCC1 shorten disease free survival in breast cancer. Cancer Research, (Oct)
Nagahashi M., Yamada A., Miyazaki H., Allegood JC., Aoyagi T., Huang WC., Terracina KP., Milstien S., Spiegel S., Takabe K. (2014) Determination of sphingosine-1-phospate levels in tissue interstitial fluid and lymphatic fluid utilizing novel collection techniques. Cancer Research, (Oct)
Aoyagi T., Avini D., Nagahashi M., Yamada A., Terracina KP., Huang WC., Soong J., Idowu MO, Aoki K., Milstien S., Spiegel S., Takabe K. (2014) FTY720 as a novel therapeutic approach for colon cancer carcinomatosis. Cancer Research, (Oct)
Nagahashi M., Liang J., Yamada A., Huang WC., Koyama Y., Wakai T., Milstien S., Spiegel S., Takabe K. (2014) FTY720, a Sphingosine-1-phosphate receptor modulator, as a novel targeted therapy against colitis-associated cancer. Journal of the American College of Surgeons, (Sep) 09-2014
Nagahashi M., Yamada A., Aoyagi T., Terracina KP., Koyama Y., Wakai T., Takabe K. (2014) Sphingossine-1-Phosphate Signaling Targeted Therapy Suppresses Obesity-Related Breast Cancer Progression and Improves survival. Journal of the American College of Surgeons, (Sep)
Aoyagi T., Avni D., Yamada A., Nagahashi M., Huang W., Terracina KP., Milstien S., Spiegel S., Takabe K. (2014) Tumor Associated Macrophages and TNF-Alpha Production in CT26 Syngeneic Murine Colon Cancer Peritoneal Carcinomatosis can be Suppressed by Inhibition of Sphingosine-1- Phosphate Signaling. Journal of Surgical Research, (Feb)
Aoyagi T., Yamada A., Nagahashi M., Huang W., Terracina KP., Milstien S., Spiegel S., Takabe K. (2014) Targeting Sphingosine-1-Phosphate Signaling with FTY720 Suppresses Colon Cancer Peritoneal Carcinomatosis Progression in Both CT26 Syngeneic and HCT116 Xenograft Models. Journal of Surgical Research, (Feb)
Nagahashi M., Yamada A., Aoyagi T., Huang W., Allegood J., Milstien S., Spiegel S., Takabe K. (2014) Targeting the Sphingosine-1-phosphate Signaling with FTY720 in Obesity Related Breast Cancer Progression. Journal of Surgical Research, (Feb)
Aoyagi T., Yamada A., Nagahashi M., Huang WC., Terracina KP., Avni D., Milstien S., Spiegel S., Takabe K. (2014) FTY720, a Sphingosine-1-phosphate Signaling Modulater, as a Novel Therapy for Colon Cancer Peritoneal Carcinomatosis. Annals of Surgical Oncology, (Feb)
Aoyagi T., Yamada A., Nagahashi M., Huang W., Terracina KP., Milstien S., Spiegel S., Takabe K. (2014) Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes with 5-fluorouracil and Prolongs Survival in a CT26 Syngeneic Murine Colon Cancer Carcinomatosis Model. Journal of Surgical Research, (Feb)
Nagahashi M., Yamada A., Aoyagi T., Huang WC, Allegood J., Milstien S., Spiegel S., Takabe K. (2014) Sphingosine-1-phosphate Signaling Exacerbates Obesity-related Breast Cancer Progression. Annals of Surgical Oncology, (Feb)
Yamada A., Nagahashi M., Aoyagi T., Huang W., Kida K., Milstien S., S;iegel S., Ishikawa T., Endo I,, Takabe K. (2014) Co-Expression of Activated Sphingosine Kinase 1 and ATP-Binding Cassette Transporter C1 (ABCC!) in Breast Cancer is Associated with Significantly Shorter Disease Free Survival. Journal of Surgical Research, (Feb)
Terracins KP., Adams BJ., Rashid OM., Yamada A., Nagahashi M., Ramachandran S., Milstien S., Spiegel S., Takabe K. (2014) Effect of Sphingosine-1-Phosphate Signaling Disruption in a Murine Synergenic Metastatic Breast Cancer Model. Journal of Surgical Research, (Feb)
Nagahashi M., Yamada A., Aoyagi T., Huang WC., Allegood JC., Milstien S., Spiegel S., Takabe K. (2013) Does the lipid mediator sphingosine-1-phosphate have a role in obesity-related cancer progression?. Cancer Research, (Dec)
Takabe K. (2013) Expression of ATP-binding cassette transporter C1 (ABCC1) and activated sphingosine kinase 1 in breast cancer are associated with significantly shorter disease free survival. Cancer Research, (Dec)
Nagahashi M., Liang J., Kim EY., Harikumar KB., Yamada A., Huang WC., Hait NC., Allegood JC., Price M., Avni D., Takabe K, Kordula T., Milstien S., Spiegel S. (2013) Abstract LB-325: Sphingosine-1-Phosphate Links Chronic Intestinal Inflammation to Development of Colitis-Associated Cancer. Cancer Research, (Apr)
Yamada A., Liang J., Nagahashi M., Kim EY., Harikumar KB., Huang WC., Hait NC., Allegood JC., Avni D., Kordula T., Milstien S., Takabe K, Spiegel S. (2013) Abstract 4887: FTY720 prevent tumorigenesis and suppress the progression of colitis-associated cancer. Cancer Research, (Apr)
Nagahashi M., Kim EY., Yamada A., Ramachandran S., Allegood JC., Hait N., Maceyka M., Milstien S., Spiegel S., Takabe K. (2013) Abstract 5000: Spinster 2 exports S1P, an important player in lymph node metastasis”. Cancer Research, (Apr)
Aoyagi T., Yamada A., Nagahashi M., Milstien S., Spiegel S., Takabe K. (2013) The sphingosine-1-phosphate receptor modulator FTY720 synergistically inhibits colon cancer cell growth with 5-fluorouracil, irinotecan and oxaliplatin. Cancer Research, (Apr)
Aoyagi T., Yamada A., Nagahashi M., Milstien S., Spiegel S., Takabe K. (2013) The Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes with 5-FU and Irinotecan in Colon Cancer Cell Killing. Annals of Surgical Oncology, (Feb)
Aoyagi T., Yamada A., Nagahashi M., Adams BJ, Milstien S., Spiegel S., Takabe K. (2013) The Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes With 5-FU to Inhibit Growth of Human Colon Cancer Cells. Journal of Surgical Research, (Feb)
Yamada A., Ishikawa T., Ota I., Kimura M., Shimizu D., Tanabe M., Aoyagi T., Nagahashi M., Chishima T., Sasaki T., Ichikawa Y., Takabe K, Endo I. (2013) The Impact of High Expression of an ATP-binding Cassette Transporter, ABCC11, in Breast Cancer Subtypes and Survival. Annals of Surgical Oncology, (Feb)
Nagahashi M., Kim EY., Yamada A., Ramachandran S., Allegood J., Hait NC., Maceyka M., Milstien S., Spiegel S., Takabe K. (2013) The Sphingolipid Transporter Spns2 Maintains Levels of Sphingosine-1-Phosphate in the Lymphatic System and Regulates Lymphatic Vessel Networks. Annals of Surgical Oncology, (Feb)
Nagahashi M., Allegood J., Yamada A., Aoyagi T., Huang W., Miyazaki H., Milstien S., Spiegel S., Takabe K. (2013) Development of a New Method to Measure Sphingosine-1-phosphate in Tumor Interstitial Fluid by Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry. Journal of Surgical Research, (Feb)
Yamada A., Ishikawa T., Ota I., Kimura M., Shimizu D., Tanabe M., Aoyagi T., Nagahashi M., Chishima T., Sasaki T., Ichikawa Y., Takabe K, Endo I. (2013) ATP-binding Cassette Transporter ABCC11 is Highly Expressed in Aggressive Breast Cancer Subtypes and Related With Worse Disease-free Survival. Journal of Surgical Research, (Feb)
Rashid OM., Nagahashi M., Ramachandran S., Dumur C., Schaum J., Milstien S., Spiegel S., Takabe K. (2013) Appropriateness of Models of Cancer Cell Implantation to Study Breast Cancer Lung Metastasis Evaluated by Genome-Wide Microarray Analysis. Journal of Surgical Research, (Feb)
Takabe K. (2012) Development of FTY720 as a Novel Treatment That Targets Obesity-Associated Breast Cancer. Journal of Women's Health, (Oct)
Wang Y., Nagahashi M., Takabe K, Gurley EC., Hylemon P., Pandak WM., Zhang L., Zhou H. (2012) Tu1820 Sphingosine Kinase 2 Deficiency Disrupts Hepatic Lipid Metabolism. Gastroenterology, (May)
Yamada A., Nagahashi M., Ramachandran S., Kim EY., Allegood JC., Rashid OM., Milstien S., Spiegel S., Takabe K. (2012) Abstract 5280: Activation of sphingosine kinase 1 is necessary for angiopoietin 2-induced hemangiogenesis and lymphangiogenesis. Cancer Research, (Apr)
Nagahashi M., Ramachandran S., Kim EY., Allegood JC., Rashid OM., Yamada A., Zhao R., Milstien S., Zhou H., Spiegel S., Takabe K. (2012) Abstract 4364: S1P generated by SphK1 is important not only for primary tumor growth but also for tumor-induced hemangiogenesis and lymphangiogenesis. Cancer Research, (Apr)
Takabe K. (2012) Evaluation of cancer cell implantation method to generate murine metastatic breast cancer model for translational research and drug development. Journal of Women’s Health, (Apr)
Rashid OM., Nagahashi M., Dumur C., Ramachandran S., Takabe K. (2012) Genome-wide Microarray Analysis Demonstrates Significantly Different Tumor Gene Expression Profiles between Sites of 4T1 Cell Implantation. Journal of Surgical Research, (Feb)
Rashid OM., Nagahashi M., Ramachandran S., Graham L., Bear HD., Takabe K. (2012) Primary Tumor Resection Decreased the Number of Myeloid Derived Suppressor Cells and Increased CD4 and CD8 Cells. Journal of Surgical Research, (Feb)
Rashid OM., Nagahashi M., Ramachandran S., Takabe K. (2012) Surgical Stress and Removal of Primary Lesion Influence Breast Cancer Progression, but Survival is Determined by Overall Tumor Burden. Journal of Surgical Research, (Feb)
Adams BJ., Nagahashi M., Ramachandran S., Hait N., Milstien S., Spiegel S., Takabe K. (2012) Targeting Breast Cancer Metastasis Using FTY720. Journal of Surgical Research, (Feb) 02-2012
Adams BJ, Nagahashi M., Ramachandran S., Hait NC., Milstien S., Spiegel S., Takabe K. (2012) The Preclinical Development of FTY720, a Sphingosine-1-Phosphate Receptor Modulator, as a Novel Targeting Therapy against Breast Cancer. Journal of Surgical Research, (Feb)
Takabe K, Nagahashi M., Ramachandran S., Kim EY., Rashid OM., Milstien S., Spiegel S. (2011) Sphingosine-1-phosphate Axis as a Novel Target for Metastatic Breast Cancer by Suppression of Angiogenesis and Lymphangiogenesis. Journal of Women’s Health, (Oct)
Nagahashi M., Ramachandran S., Kim EY., Allegood JC., Rashid OM., Milstien S., Spiegel S., Takabe K. (2011) Specific inhibitor of sphingosine kinase 1 suppresses tumor-induced angiogenesis and lymphangiogenesis. Journal of the American College of Surgeons, (Oct)
Nagahashi M., Rashid OM., Ramachandran S., Milstien S., Spiegel S., Takabe K. (2011) Effect of sphingosine kinase 1 inhibition in validated syngeneic mouse breast cancer metastasis model. Cancer Research, (Jul)
Rashid OM., Nagahashi M., Ramachandran S., Takabe K. (2011) Choosing The Right Translational Animal Model Matters: Subcutaneous Versus Orthotopic Implantation of Mouse Breast Cancer Differentially Expresses Genes Important For Cancer Research And Drug Development. Journal of Surgical Research, (Feb)
Ramachandran S., Shida D., Nagahashi M., Ramachandran S., Milstien S., Takabe K. (2011) Abstract 4103: Sphingosine kinase-1 mediates LPA-induced gastric cancer cell proliferation. Cancer Research, (Jan)
Rashid OM., Nagahashi M., Ramachandran S., Milstien S., Spiegel S., Takabe K. (2011) Abstract 475: Resection of primary tumor improves survival in mouse metastatic breast cancer model. Cancer Research, (Jan)
Nagahashi M., Ramachandran S., Rashid OM., Milstien S., Spiegel S., Takabe K. (2011) Targeting sphingosine kinase 1 is promising novel strategy against breast cancer. Cancer Research, (Jan)
Takabe K. (2010) Are We Using the Appropriate Mouse Model to Study Breast Cancer Progression. Journal of Women's Health, (Oct)
Nagahashi M., Kim RH., Allegood JC., Ramachandran S., Spiegel S., Takabe K. (2010) Estradiol-Induced Sphingosine-1-Phosphate Is Released via ABCC1 and ABCG2, and Activates ERK1/2. Journal of Surgical Research, (Feb)
Rashid OM., Kim RH., Allegood JC., Ramachandran S., Nagahashi M., Spiegel S., Takabe K. (2010) Non-Genomic ER-Alpha but Not GPR30 Is Involved in Estradiol-Mediated Release of Sphingosine-1-Phosphate from Breast Cancer. Journal of Surgical Research, (Feb)
Nagahashi M., Ramachandran S., Rashid OM., Milstien S., Spiegel S., Takabe K. (2010) Sphingosine Kinase 1: A New Target Against Breast Cancer. Annals of Surgical Oncology, (Feb)
Takabe K, Allegood JC., Kim RH., Mitra P., Ramachandran S., Nagahashi M., Harikumar KB., Hait NC., Milstien S., Spiegel S. (2009) Estradiol-Mediated Export of Sphingosine 1-Phosphate from Breast Cancer Cell Is Via Non-Genomic Effect of Estrogen Receptor and Not GPR30. Journal of Women’s Health, (Oct)
Kim RH., Takabe K, Allegood JC., Mitra P., Spiegel S. (2009) Estradiol, but not Epidermal Growth Factor, stimulates rapid production and export of sphingosine 1-phosphate from human breast cancer cells. Annals of Surgical Oncology, (Feb)
Takabe K, Mitra P., Spiegel S. (2008) The role of ABC transporter in export of sphingosine 1-phosphate from breast cancer cell. Journal of Women’s Health, (Oct)
Takabe K, Mitra P., Spiegel S. (2008) ABC transporters, ABCC1 and ABCG2, are involved in estradiol-induced export of sphingosine 1-phospate from human breast cancer cells. AACR Annual. AACR Annual Meeting 2008 Proceedings, (Apr)
Tomiya T., Takabe K, Inoue Y., Tejima K., Ikeda H., Nishikawa T., Watanable N., Ohtomo N., Omata M., Vale W., Fujiwara K. (2007) Serum follistatin levels as a marker of hepato-gastrointestinal carcinomas. Journal of Gastroenterology and Hepatology, (Jan)
Takabe K, Tomiya T., Vale W. (2007) Serum Follistatin Levels Immediately after Hepatectomy Predict the Extent of Liver Regeneration. Annals of Surgical Oncology, (Jan)
Takabe K. (2006) Hernia Sac Laparoscopy under Spinal Anesthesia for Evaluation of Reduced Incarcerated Inguinal Hernia. Surgical Endoscopy and Other Interventional Techniques, (Jan)
Yen TY., Kalmaz D., Takabe K, Acosta JA., Hunt GC. (2006) Massive lower gastrointestinal bleeding in a patient newly diagnosed with human immunodeficiency virus. American Journal of Gastroenterology, (Jan)
Takabe K, Tomiya T., Vale W. (2004) Serum Follistatin Levels Predict the Extent of Liver Regeneration after Hepatectomy in Human and Rat Models. Journal of the American College of Surgeons, (Jan)
Takabe K, Vale W. (2003) Activin inhibits liver regeneration from overgrowing. Journal of the American College of Surgeons, (Jan)
Tomiya T., Takabe K, Inoue Y., Tejima K., Yanase M., Arai M., Ikeda H., Vale W., Fujiwara K. (2002) Serum Follistatin Level Predict Liver Regeneration in Hepatectomized Patients. Hepatology, (Jan)
Takabe K, Shintani Y., Kubota T., Shimada H., Vale W. (2001) Serum Follistatin Level as an Early Detection Marker of Post-hepatectomy Liver Failure: Using Our Novel Rat 90 Hepatectomy Model. Gastroenterology, (Jan)
Takabe K, Shintani Y., Kubota T., Shimada H., Vale W. (2001) Effects of Massive Liver Removal on Serum Follistatin Levels. Program, (Jan)
Takabe K, Wang L., MacConell LA., Leal AM., Wiater E., Bilezikjian LM., Verma IM., Vale W. (2000) Adenovirus-mediated Overexpression of Follistatin Results in Enlargement of the Liver in Normal Adult Rats. Hepatology, (Oct)
Takabe K, Wang L., Donaldson CJ., Wiater EM., Bilezikjian LM., Verma IM., Vale W. (2000) Adenovirus-mediated Overexpression of Follistatin Enlarge the Intact Liver in Rats. Program, (Jan)
Takabe K, Wang L., Wiater E., Bilezikjian LM., Verma IM., Vale W. (1999) Recombinant Adenovirus Vector Encoding Follistatin: A Potential Tool to Stimulate Liver Regeneration. Hepatology, (Oct)
Takabe K, Lebrun JJ., Ichikawa Y., Endo I., Fujii Y., Togo S., Shimada H. (1999) Expression of Activin in Hepatoma Cell Lines and Its Signal Transduction. The Japanese Journal of Gastroenterological Surgery, (Jan)
Lebrun JJ., Takabe K, Chen Y., Vale W. (1998) Ligand-dependent Association of Smad2 and Smad3 with the Activin Receptor Complex. Program, (Jan)
Takabe K, Ohki S., Sakashita T., Kunihiro O., Ichikawa Y., Togo S., Endo I., Shimada H. (1998) A Case of Intestinal Anisakis that Caused Strangulating Intestinal Obstruction. Journal of Kanagawa Medical Society, (Jan)
Takabe K, Ichikawa Y., Shimada H. (1998) Cell Growth Effect Using Activin A Antisense Oligonucleotide – Future Drug for Liver Regeneration. Nippon Geka Gakkai Zasshi (Journal of Japan Surgical Society), (Jan)
Takabe K, Lebrun JJ., Ichikawa Y., Vaughn J., Mitsuhashi M., Nagashima Y., Shimada H., Vale W. (1998) Use of an Antisense Oligonucleotide Approach to Assess the Role of Activin as an Anti-proliferative agent in the Liver. Program, (Jan)
Takabe K, Ichikawa Y., Nagashima Y., Kubota T., Ishikawa T., Momiyama N., Sekido H., Togo S., Nakano A., Shimada H. (1997) Activin A Expression and Suppression During Liver Regeneration – Findings using Activin A Antisense Oligo. Acta Hepatologica Japonica, (Jan)
Takabe K, Ichikawa Y., Nagashima Y., Kubota T., Ishikawa T., Momiyama N., Sekido H., Togo S., Nakano A., Shimada H. (1997) Activin A and its Antisense Oligonucleotide – As a Marker of Liver Regeneration and as an Accelerator. Nippon Geka Gakkai Zasshi (Journal of Japan Surgical Society), (Jan)
Takabe K, Ichikawa Y., Nagashima Y., Ishikawa T., Momiyama N., Eto Y., Mitsuhashi M., Shimada H. (1997) Activin A Antisense Oligodeoxynucleotides Accelerate Hepatic Cell Proliferation. Gastroenterology, (Jan)
Takabe K, Ichikawa Y., Nagashima Y., Kubota T., Ishikawa T., Momiyama N., Sekido H., Togo S., Nakano A., Shimada H. (1997) Expression of Activin A mRNA After Hepatectomy – Can it be a Marker of Liver Regeneration?. The Japanese Journal of Gastroenterological Surgery, (Jan)
Takabe K, Tetsuya Ohtani T., Ichiro Muto I., Yukio Takano Y. (1996) Outcome of the Treatments of Thyroid Cancer Recurrence. Journal of Niigata Medical Society, (Jan)
Takabe K, Ichikawa Y., Ishikawa T., Momiyama N., Nagashima Y., Shimada H. (1996) Quantitative Detection of Activin A mRNA in The Liver by Competitive PCR. Hepatology, (Jan)
Takabe K, Nakano A., Shimada H. (1996) Mechanism of Worsening of Postoperative Sepsis and Its Treatment. Journal of United Surgical Association of Japan, (Jan)

See all (81 more)

Professional Memberships:

Society of University Surgeons (2014–present)
Southern Surgical Association (2014–present)
Surgical Biology Club (2013–present)
Richmond Academy of Medicine (2013–present)
American Society of Breast Surgeons (2010–present)
American Society of Breast Disease (2009–present)
Massey Cancer Center Cancer Cell Signaling group member (2008–present)
Medical Society of Virginia (2008–present)
American Association for the Advancement of Science (2008–present)
Association for Academic Surgery (2008–present)
American Association for Cancer Research (2007–present)
Society of Surgical Oncology (2007–present)
Japanese Medical Society of America (2007–present)
American Society of Clinical Oncology (2007–present)
American Medical Association (2006–present)
The Society of American Gastrointestinal and Endoscopic Surgeons (2005–present)
The American Board of Hospital Physicians (2003–present)
American College of Surgeons (2003–present)
American Hepato-Pancreato-Biliary Association (2003–present)
The Endocrine Society (1999–present)
International Association of Surgeons, Gastroenterologists and Oncologists (1998–present)
International Liver Transplantation Society (1998–present)
Japan Gastrointestinal Surgery Society (1993–present)
Japan Surgical Society (1993–present)
The Japanese Society of Gastroenterology (1993–present)

See all (15 more)

Presentations:

"“852299: Murine radical mastectomy model for preclinical study of adjuvant systemic therapies”" 2016 San Antonio Breast Cancer Symposium (2016)
"“852300: Combination of Doxorubicin with S1P signaling modulator FTY720 significantly suppressed obesity associated breast cancer”" 2016 San Antonio Breast Cancer Symposium (2016)
"Breast Cancer Care and Research at Roswell Park Cancer Institute" Learning Academy at Amberleigh Retirement Community (2016)
"Challenges of a Breast Surgery Chair at Roswell Park Cancer Institute" Yokohama City University Reception (2016)
"How to make a surgeon American way" Tokyo Medical University Medical Student Lecture (2016)
"Precision Medicine and Our Challenges" Denka Invited Lecture (2016)
"Research Topics that a Surgical Trainee can Accomplish" RPCI Surgical Oncology Grand Rounds (2016)
"Role of S1P in cancer progression and microenvironment" Yokohama City University Graduate School Seminar (2016)
"Success is not to keep up, but to get up as many as falling" Niigata University project for promotion of global human resource development Medical Student Lecture (2016)
"Update on Genomic Medicine in the US" Yakult Meeting (2016)
"What can be achieved as a Chief of Breast Surgery at Roswell Park Cancer Institute" Memorial Lecture (2016)
"What is research by surgeons" Tsumura Meeting at Yujin Memorial Hall; ; Niigata University (2016)
"Vision of Roswell Park Cancer Institute Breast Surgery Division" Buffalo Sabres Alumni Luncheon (RPCI) (2016)
"“Murine Radical Mastectomy Model for the Drug Development of Adjuvant Therapies”" Post Doc Symposium (RPCI) (2016)
"“Novel Subclassification using MicroRNA Expression Patterns of Breast Cancer with Significant Clinical Relevance” K" Post Doc Symposium (2016)
"Murine Models that Mimic Human Cancer Progression and Rose of Sphingosine-1-phosphate (S1P) in cancer progression" RPCI Experimental Therapeutics Program Retreat (RPCI) (2016)
"Appropriate mice models to address this question - A surgeon's perspective-" RPCI Retreat (2016)
"Closing Remark of the fourth US-Japan Clinical Trials in Oncology Workshop" Fourth US-Japan Clinical Trials in Oncology Workshop; ; Japan Society (2016)
"“Current Practice of Precision Medicine in the US”" Next Generation Sequencing Diagnostics for Optimal Treatment; Japan Meeting at ASCO 2016 (2016)
"Remaris" Welcome Reception (RPCI) (2016)
"“Conjugated bile acids aggravate metastatic pancreatic cancer via sphingosine1phosphate receptor 2”" The 107th Annual Meeting American Association of Cancer Research (2016)
"“Newer platinum agent, Triplatin NC, is as effective as Triplatin for metastatic breast cancer and pancreatic cancer carcinomatosis”" The 107th Annual Meeting American Association of Cancer Research (2016)
"“How Fast Can the Immune Response Eliminate Murine Cancer Cells from a Different Background?”" Society of Surgical Oncology's 69th Annual Cancer Symposium (2016)
"“How to survive as a Physician/Scientist”" National Health Institute Kinyokai (2016)
"“P401: Conjugated Bile Acid Promote the Proliferation of Pancreatic Cancer via Sphingosine 1-Phosphate Receptor 2”" Society of Surgical Oncology's 69th Annual Cancer Symposium (2016)
"“P405: Inflammation Induced by Sphingosine Kinase of the Host Aggravates Pancreatic Cancer Peritoneal Carcinomatosis”" Society of Surgical Oncology's 69th Annual Cancer Symposium (2016)
"“Sphingosine-1-phosphate Signaling Targeted by FTY720 Suppress Obesity-related Breast Cancer Progression, Metastasis, and Improve Survival”" Society of Surgical Oncology Annual Meeting 2016 (2016)
"“Are Animal Models Useful For Training a Preclinical Medical Student?”" 11th Annual Academic Surgical Congress (2016)
"“Establishment of a Novel Murine Model of Obstructive Jaundice”" 11th Annual Academic Surgical Congress (2016)
"“Expression of VEGFA and VEGFR correlates with Disease Free and Overall Survival in Colorectal Cancer”" 11th Annual Academic Surgical Congress (2016)
"“Factors and Methods to Improve the Success Rate of Intravenous Catheterization by Medical Students” Woelfel" 11th Annual Academic Surgical Congress (2016)
"“Gene expression of Angiopoietin, Tie and VEGF are associated with poor survival in breast cancer”" 11th Annual Academic Surgical Congress (2016)
"“Murine Breast cancer cells eliminated in non-derived strain mice; using an improved breast cancer model”" 11th Annual Academic Surgical Congress (2016)
"“Obstructive Jaundice Aggravate Pancreatic Cancer via Sphingosine 1 Phosphate Receptors”" 11th Annual Academic Surgical Congress (2016)
"“Platinum Agents, Triplatin and TriplatinNC, Suppress 4T1 Murine Breast Cancer Lung Metastasis”" 11th Annual Academic Surgical Congress (2016)
"“Role of Sphingosine-1-phoshate of the Host in Progression of Pancreatic Cancer Carcinomatosis”" 11th Annual Academic Surgical Congress (2016)
"Image-based Density/Elasticity Guided Biopsy to Overcome Cancer Heterogeneity" VCU Surgery - School of Engineering Research Meeting (2015)
"“Obesity increases the lipid mediator, sphingosine-1-phosphate in the tumor and tumor microenvironment, and promotes tumor progression”" 2015 San Antonio Breast Cancer Symposium (2015)
"“Sphingosine-1-phosphate signaling promotes metastatic niches and lung metastasis in obesity-related breast cancer”" 2015 San Antonio Breast Cancer Symposium (2015)
"“Conjugated bile acid aggravate metastatic pancreatic cancer both in vitro and in vivo”" 50th Southeastern Regional Lipid Conference (SERLC 2015) (2015)
"“Establishment of a mouse model that mimic human breast cancer progression”" 50th Southeastern Regional Lipid Conference (SERLC 2015) (2015)
"“What is wrong being fat?”" 25th Medical Lecture for Japanese Society in Virginia,; ; The Japan-Virginia Society (2015)
"“Angiogenesis Gene Expression and Poor Outcomes in Breast Cancer”" VCU Department of Surgery Research Day (2015)
"“Appropriate amount of Matrigel to be inoculated in C57BL/6 mice mammary glands”" 2015 VCU Massey Cancer Center Research Retreat (2015)
"“Gene silencing of SphK1 with novel nanoparticles as an innovative approach against cancer progression”" Medical Student Honors Day (2015)
"“Role of Sphingosine Kinase 1 of the Host in the Progression of Pancreatic Cancer Peritoneal Carcinomatosis”" 2015 VCU Massey Cancer Center Research Retre (2015)
"“Social media is rapidly expanding. How can ASCO employ new communication methods to best serve its members and the larger organization?”" American Society of Clinical Oncology Board Meeting at 2015 ASCO 51st Annual Meeting (2015)
"“The use of novel carbonate apatite nanoparticles in 4T1 murine breast cancer cells to down regulate sphingosine kinase 1 and inhibit migration”" 2015 VCU Massey Cancer Center Research Retreat (2015)
"Closing Remark of the third US-Japan Clinical Trials in Oncology Workshop" Third US-Japan Clinical Trials in Oncology Workshop (2015)
"Role of Sphingosine-1-phosphate (S1P) in Tumor Microenvironment& Cancer Progression" Virginia Commonwealth University; ; Department of Biology (2015)
"“Are the genomic gene expression profiles maintained between the original donor and patient-derived xenograft tumors?”" The 106th Annual Meeting American Association of Cancer Research (2015)
"“FTY720 suppressed CT26 murine colon cancer peritoneal carcinomatosis progression by decreasing tumor associated macrophages and TNF-alpha” ”" The 106th Annual Meeting American Association of Cancer Research (2015)
"“How a Surgeon/Scientist who does research on role of sphingolipids in cancer survived”" ; University of Pennsylvania (2015)
"“Obesity increase sphingosine-1-phosphate in tumor microenvironment”" Annual meeting of Japan Surgical Society (2015)
"“Surgeon/Scientist on Sphingolipid research - Turning the weakness into strength”" New York Life Science Forum 2015 at New York University; Langone Medical Center; Japanese Medical Society in America (JMSA) (2015)
"“Introducing J-RAV (Japanese Researchers’ Association in VCU)”" “Introducing J-RAV (Japanese Researchers’ Association in VCU)”; ; United Japanese Researchers Association (UJA) (2015)
"“Is Patient Derived Xenograft Model Appropriate for Colon Cancer Preclinical Drug Development?”" Annual meeting of Society of Surgical Oncology (2015)
"“Modified orthotopic murine colon cancer cell implantation method that mimics clinical cancer progression”" Annual meeting of Society of Surgical Oncology (2015)
"“Gene silencing of SphK1 with nanoparticles as an innovative approach against cancer progression”" 10th Annual Academic Surgical Congress (2015)
"“Improvements to a Murine Colon Cancer Model for Cancer Progression and the Tumor Microenvironment”" 10th Annual Academic Surgical Congress (2015)
"“Role of sphingosine kinase 1 of the host in the progression of pancreatic cancer peritoneal carcinomatosis”" 10th Annual Academic Surgical Congress (2015)
"“Role of Sphingosine-1-Phosphate in Inflammation-Induced Lymphangiogenesis”" 10th Annual Academic Surgical Congress (2015)
"“S1P Forms a Feed-Forward Loop with the Ang2 and VEGF-C Pathways in Lymphangiogenesis”" 10th Annual Academic Surgical Congress (2015)
"Why Surgical Oncology" David Humes Surgical Society lunch lecture (2015)
"“Introducing J-RAV (Japanese Researchers’ Association in VCU)”" Joint United Japanese Researchers Association (UJA) and Japanese Society for Promotion of Science (JSPS) Meeting (2014)
"“Sphingosine-1-Phosphate Signaling as a Target in Inflammation-promoted Cancer Progression”" 10th Annual Academic Surgical Congress; Society of University Surgeons New Member Poster Presentations (2014)
"Cancer of the Colon" BIOL-450 Biology of Cancer I; ; Virginia Commonwealth University Lecture (2014)
"Research Environment of American Surgeon/Scientist" Panel Discussion, 76th Annual Meeting of Japan Clinical Surgery Society (2014)
"Role of Sphingosine-1-phosphate (S1P) in Tumor Microenvironment and Cancer Progression" Massey Cancer Center Cancer Cell Signaling Program Retreat (2014)
"“Closing Remarks by the Conference Chair”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
"“Conjugated Bile Acid Activated S1P Receptor 2 Is a Key Regulator of Sphingosine Kinase 2 and Hepatic Gene Expression”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
"“FTY720 Decrease Sphingosine-1-phosphate in the Tumor Interstitial Fluid Collected by Novel Methods”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
"“Opening Remarks by the Conference Chair”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
"“Patient-Derived Xenograft Murine Model Does Not Reproduce Sphingosine-1-Phosphate Signaling of the Original Patient Colon Cancer”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
"“Primary colon cancer model for analysis of tumor microenvironment and cancer progression”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
"“Sphingosine-1-phosphate produced by sphingosine kinase 1 and exported via ABCC1 shortens breast cancer survival”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
"“Targeting sphingosine-1-phosphate signaling with FTY720 suppresses progression of colon cancer peritoneal carcinomatosis and prolongs survival”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
"“Activated SphK1 and export of S1P via ABCC1 shorten disease free survival in breast cancer”" NIH-Japan-JSPS Symposium: Highlights from the Frontier of Biomedical Science from NIH and Japan, Lipsett Auditorium of NIH (2014)
"“FTY720, a sphingosine-1-phosphate receptor modulator, as a novel targeted therapy against colitis-associated cancer”" American College of Surgeons Annual Clinical Congress (2014)
"“Role of Sphingosine-1-phosphate (S1P) in cancer progression”" Annual meeting of the Surgical Biology Club (2014)
"“Sphingosine-1-phosphate signaling targeted therapy suppresses obesity-related breast cancer progression and improves survival”" American College of Surgeons Annual Clinical Congress (2014)
"Obesity and Sphingosine-1-phosphate" Cancer and Metabolism Working Group Meeting (2014)
"“At What Age Should We Recommend Screening Mammography for Asian Women?”" VCU Surgical Oncology Conference (2014)
"“Role of Sphingosine-1-phosphate (S1P) in tumor microenvironment and cancer progression”" Hollings Cancer Center at Medical University South Carolina. (2014)
"Role of Sphingosine-1-phosphate (S1P) in Tumor Microenvironment and Cancer Progression" VCU Surgery Grand Rounds (2014)
"“Evaluation of fingolimod as a treatment strategy in metastatic breast cancer”" The 11th Annual VCUHS Resident/Fellow Research Day at VCU (2014)
"“Sphingosine-1-phospahte Signaling in Cancer Progression and Cancer Therapy”" VCU Department of Surgery Research Conference (2014)
"“SphK1-S1P-S1PR1 axis inhibition results in anti-tumor effects in a murine model of colon cancer peritoneal carcinomatosis”" The 11th Annual VCUHS Resident/Fellow Research Day at VCU (2014)
"“Advanced murine models of colon cancer progression and metastasis”" VCU Department of Surgery Research Day (2014)
"“An improved syngeneic colon cancer model for studies in cancer progression and metastasis”" 2014 VCU Massey Cancer Center Research Retreat (2014)
"“Development of a syngeneic orthotopic murine colon cancer model for preclinical studies targeting the tumor microenvironment”" Virginia Surgical Society (2014)
"“FTY720 suppress colon cancer peritoneal carcinomatosis progression by targeting sphingosine-1-phosphate signaling and suppressing tumor-associated macrophages”" 2014 VCU Massey Cancer Center Research Retreat (2014)
"“New methods for measurement of sphingosine-1-phosphate in tissue interstitial fluid and lymphatic fluid for analysis of tumor microenvirionment”" 2014 VCU Massey Cancer Center Research Retreat (2014)
"“Outcomes of hybrid VATS for pulmonary metastasectomy”" VCU Department of Surgery Research Day (2014)
"“Overexpression of ABCC1, but not ABCB1, correlates with breast cancer patient survival”" 2014 VCU Massey Cancer Center Research Retreat (2014)
"“Preclinical evaluation of FTY720 as a novel therapeutic for colon cancer peritoneal carcinomatosis" Virginia Chapter, American College of Surgeons (2014)
"“Preclinical evaluation of FTY720 targeting S1P signaling for colon cancer peritoneal carcinomatosis”" VCU Department of Surgery Research Day (2014)
"“Sphingosine-1-phosphate signaling: A novel therapeutic target for obesity-related breast cancer metastasis”" VCU Massey Cancer Center Research Retreat (2014)
"“STAT3 interacts with cyclophilin D in cancer cells to regulate the MPTP”" 2014 VCU Massey Cancer Center Research Retreat (2014)
"Role of Sphingosine-1-phosphate in inflammation and cancer" Department of Microbiology and Immunology Graduate Student Seminar (2014)
"“Activated SphK1 and export of S1P via ABCC1 Shorten Disease Free Survival in Breast Cancer”" The 105th Annual Meeting American Association of Cancer Research (2014)
"“Breast cancers that co-express ABCC1 and Sphingosine kinase 1 have poor prognosis”" Annual meeting of Japan Surgical Society (2014)
"“Determination of Sphingosine-1-phosphate levels in Tissue Interstitial Fluid and Lymphatic Fluid Utilizing Novel Collection Techniques”" The 105th Annual Meeting American Association of Cancer Research (2014)
"“FTY720 as a novel therapeutic approach for colon cancer carcinomatosis”" The 105th Annual Meeting American Association of Cancer Research (2014)
"“Sphingosine-1-phosphate in Breast and Colon Cancer”" ASONEP Advisory Panel Meeting. (2014)
"“Targeting sphingosine-1-phosphate signaling as a therapeutic strategy for breast cancer lung metastasis”" The 10th Annual VCU Women’s Health Research Day (2014)
"American surgeon/scientist-forefront of targeted therapy development" Aiseki Gastrointestinal Surgery Seminar at the Jikei University (2014)
"Targeting S1P by FTY720 in obesity-related inflammation and breast cancer metastasis" Breast Cancer Research Interest Group Meeting; ; Massey Cancer Center (2014)
"What it means to work internationally" International Career Symposium; ; Niigata University Global Workforce Development Program (2014)
"“FTY720, a functional antagonist of sphingosine-1-phosphate signaling, as a novel therapy for colon cancer peritoneal carcinomatosis”" 67th Annual Cancer Symposium, the Society of Surgical Oncology (2014)
"“Sphingosine-1-phosphate signaling exacerbates obesity-related breast cancer progression”" 67th Annual Cancer Symposium, the Society of Surgical Oncology (2014)
"Cancer Epidemiology and Prevention" Junior General Surgery Resident Basic Science Lecture series (2014)
"“Co-Expression of Activated Sphingosine Kinase 1 and ATP-Binding Cassette Transporter C1 (ABCC1) in Breast Cancer is Associated with Significantly Shorter Disease Free Survival”" 9th Annual Academic Surgical Congress (2014)
"“Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes with 5-fluorouracil and Prolongs Survival in a CT26 Syngeneic Murine Colon Cancer Carcinomatosis Model”" 9th Annual Academic Surgical Congress (2014)
"“Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes with 5-fluorouracil and Prolongs Survival in a CT26 Syngeneic Murine Colon Cancer Carcinomatosis Model”" 9th Annual Academic Surgical Congress (2014)
"“Targeting Sphingosine-1-Phosphate Signaling with FTY720 Suppresses Colon Cancer Peritoneal Carcinomatosis Progression in Both CT26 Syngeneic and HCT116 Xenograft Models”" 9th Annual Academic Surgical Congress (2014)
"“Targeting the Sphingosine-1-phosphate Signaling with FTY720 in Obesity Related Breast Cancer Progression”" 9th Annual Academic Surgical Congress (2014)
"“Tumor Associated Macrophages and TNF-Alpha Production in CT26 Syngeneic Murine Colon Cancer Peritoneal Carcinomatosis can be Suppressed by Inhibition of Sphingosine-1-Phosphate Signaling”" 9th Annual Academic Surgical Congress (2014)
"“Role of Sphingosine-1-phosphate in cancer progression”" National Institute of Health Kinyokai Seminar. (2014)
"“Sphingosine-1-phosphate signaling as a novel therapeutic target for obesity related breast cancer metastasis”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
"“ATP-binding cassette transporter C1 (ABCC1) expression in the presence of sphingosine-1-phosphate (S1P) production is associated with significantly shorter disease free survival”" 2013 San Antonio Breast Cancer Symposium (2013)
"“Does the lipid mediator Sphingosine-1-phosphate have a role in obesity-related cancer progression?”" 2013 San Antonio Breast Cancer Symposium (2013)
"“Role of S1P in obesity-related breast cancer progression" Breast Cancer Research Interest Group Meeting at Massey Cancer Center (2013)
"Role of S1P signaling in Cancer" Molecular Pathology Collaborators Meeting (2013)
"“Advanced murine orthotopic model systems for the study of lipid signaling in cancer progression”" 48th Annual SouthEastern Regional Lipid Conference (2013)
"“Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer”" 48th Annual SouthEastern Regional Lipid Conference (2013)
"S1P signaling as a novel target for colon cancer peritoneal carcinomatosis" VCU Surgical Oncology Conference (2013)
"What can we do to achieve benchmarks for Massey to become a Comprehensive Cancer Center?" Breast Cancer Research Interest Group Meeting at Massey Cancer Center (2013)
"“So you want to be a Doctor”" CODE:13Fall-07 Saturday Enrichment Program for Gifted Learners; The College of William and Mary; Center for Gifted Education (2013)
"45 year old man with progressive abdominal swelling'" Department of Internal Medicine Clinicopathologic Conference (2013)
"Closing Remark of the second US-Japan Clinical Trials in Oncology Workshop" Second US-Japan Clinical Trials in Oncology Workshop (2013)
"Physician/Scientists in the US" Japanese Researchers' Association in VCU (2013)
"“Co-expression of sphingosine kinase 1 and ATP-bindign cassette transorter C1 (ABCC1) in human breast cancers correlates with significantly shorter disease free survival”" 2013 VCU Massey Cancer Center Research Retreat (2013)
"“SphK1-S1P-S1PR1 axis is essential for persistent activation of STAT3 and connects chronic inflammation and colitis-associated cancer”" 2013 VCU Massey Cancer Center Research Retreat (2013)
"“STAT3 interacts with cyclophilin D in cancer cells to regulate the MPTP”" 2013 VCU Massey Cancer Center Research Retreat (2013)
"“Targeting sphingosine-1-phosphate signaling with FTY720 inhibits CT26 and HCT116 colon cancer progression in peritoneal carcinomatosis models" 2013 VCU Massey Cancer Center Research Retreat (2013)
"“The role of sphingosine-1-phosphate in obesity-related cancer progression”" 2013 VCU Massey Cancer Center Research Retreat (2013)
"“FTY720 prevents tumorigenesis and suppresses the progression of colitis-associated cancer”" The 104th Annual Meeting American Association of Cancer Research (2013)
"“FTY720, a sphingosine-1-phosphate receptor type 1 (S1PR1) modulator, suppresses obesity-related breast cancer progression in two animal models”" The 9th Annual VCU Women’s Health Research Day (2013)
"“Human breast cancers that co-express sphingosine kinase 1 and ABCC1 have significant shorter disease free survival”" The 9th Annual VCU Women’s Health Research Day (2013)
"“Sphingosine-1-Phosphate Links Chronic Intestinal Inflammation to Development of Colitis-Associated Cancer”" The 104th Annual Meeting American Association of Cancer Research (2013)
"“Spinster 2 exports S1P, an important player in lymph node metastasis”" The 104th Annual Meeting American Association of Cancer Research (2013)
"“The sphingosine-1-phosphate receptor modulator, FTY720, synergistically inhibits colon cancer cell growth with 5-fluorouracil, irinotecan and oxaliplatin”" The 104th Annual Meeting American Association of Cancer Research (2013)
"Being a surgeon in the US: What lies beyond your dream?" Special Lecture for Medical Students (2013)
"Is Surgeon/Scientist necessary? A case of a surgeon who researches the role of Sphingolipids in Cancer Progression" The 8th Meeting of Niigata Cross-sectional Research Group for Digestive Diseases (2013)
"Postgraduate surgical training in the US" Special Lecture for Medical Students (2013)
"Surgical Research in the US: Is physician/scientist endangered species?" Special Lecture for Surgical Residents and Staffs. (2013)
"“The impact of high expression of an ABC transporter, ABCC11, in breast cancer subtypes and survival”" 66th Annual Cancer Symposium, the Society of Surgical Oncology (2013)
"“The Sphingolipid Transporter Spns2 Maintains Levels of Sphingosine-1-Phosphate in the Lymphatic System and Regulates Lymphatic Vessel Networks”" 66th Annual Cancer Symposium, The Society of Surgical Oncology (2013)
"“The sphingosine-1-phosphate receptor modulator, FTY720, synergizes with 5-FU and irinotecan on colon cancer cell killing”" 66th Annual Cancer Symposium, the Society of Surgical Oncology (2013)
"“Appropriateness of Models of Cancer Cell Implantation to Study Breast Cancer Lung Metastasis Evaluated by Genome-Wide Microarray Analysis”" 8th Annual Academic Surgical Congress (2013)
"“ATP-binding Cassette Transporter ABCC11 is Highly Expressed in Aggressive Breast Cancer Subtypes and Related With Worse Disease-free Survival”" 8th Annual Academic Surgical Congress (2013)
"“Development of a New Method to Measure Sphingosine-1-phosphate in Tumor Interstitial Fuid by Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry”" 8th Annual Academic Surgical Congress (2013)
"“How to Use This Course to Earn a Grant”" ; The Grant Writing Workshop; Association of Academic Surgeons/Society of University Surgeons Surgical Investigators’ Course, (2013)
"“The Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes With 5-FU to Inhibit Growth of Human Colon Cancer Cells”" 8th Annual Academic Surgical Congress (2013)
"New Insights in the Mechanism of Carcinogenesis: An Overview" 22nd World Congress of the Internatioan Association of Surgeons, Gastroenterologists and Oncologists (2012)
"Novel mechanism of inflammatory bowel disease related carcinogenesis" 22nd World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (2012)
"Role of sphingolipids on development of non-alcoholic fatty liver disease" 22nd World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (2012)
"The Role of Sphingolipids in Breast Cancer Progression" TokyoBay Urayasu-Ichikawa Medical Center (2012)
"“Development of FTY720 as a Novel Treatment That Targets Obesity-Associated Breast Cancer”" Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Scholars Meeting; ; National Institute of Health (2012)
"“Clinical relevance of the high expression of ABC transporter C11, in the light of breast cancer subtypes”" 2012 VCU Massey Cancer Center Research Retreat (2012)
"“Sphingolipids in Tumor Microenvironment Measured by Liquid Chromatography-electrospray Ionization Tandem Mass Spectrometry”" 2012 VCU Massey Cancer Center Research Retreat (2012)
"“Sphingosine-1-phosphate secreted by tumors affects their microenvironment and promotes breast cancer progression”" 29th Annual Daniel T. Watts Research Poster Symposium (2012)
"“Sphingosine-1-phosphate secreted by tumors affects their microenvironment and promotes breast cancer progression”" 29th Annual Daniel T. Watts Research Poster Symposium (2012)
"“The expression of ABC transporter C11 in aggressive breast cancer subtypes is related with poor prognosis”" 29th Annual Daniel T. Watts Research Poster Symposium (2012)
"“The S1P Transporter Spinster 2 knockout mice have aberrant lymphatic sinuses”" 2012 VCU Massey Cancer Center Research Retreat (2012)
"“The Sphingosine-1-phosphate receptor modulator, FTY720, synergistically inhibit colon cancer cell growth with 5-Fluorouracil and Irinotecan”" 29th Annual Daniel T. Watts Research Poster Symposium (2012)
"“The Sphingosine-1-phosphate receptor modulator, FTY720, synergizes with 5-FU and Irinotecan to inhibit growth of colon cancer cells”" 2012 VCU Massey Cancer Center Research Retreat (2012)
"Dphinhodinr-1-phosphate Producted by Sphingosine Kinase 1 Promotes Breast Cancer Progression by Stimulating Angiogenesis and Lymphangiogenesis" Journal Club; ; VCU Department of Internal Medicine (2012)
"“Choice of the right translational mouse breast cancer model matters: subcutaneous vs. orthotopic implantation of murine breast cancer differentially express genes important for cancer research and drug development”" Department of Surgery Research Day, VCU (2012)
"“Sphingosine kinase 2 deficiency disrupts hepatic lipid metabolism”" Digestive Disease Week 2012 (2012)
"“The preclinical development of an S1P receptor type 1 targeting agent”" Department of Surgery Research Day, VCU (2012)
"“Activation of sphingosine kinase 1 is necessary for angiopoietin 2-induced hemangiogenesis and lymphangiogenesis”" The 103rd Annual Meeting American Association of Cancer Research (2012)
"“ATP-binding transporters, ABCC1 and ABCG2 are expressed higher in triple negative breast cancer”" The 8th Annual VCU Women’s Health Research Day (2012)
"“Choice of the Right Translational Mouse Breast Cancer Model Matters: Subcutaneous Versus Orthotopic Implantation of Murine Breast Cancer Differentially Express Genes Important for Cancer Research and Drug Development”" Virginia Chapter, American College of Surgeons (2012)
"“How Appropriate a Metastatic Model is Cancer Cell Implantation via Tail Vein Injection to Study Breast Cancer Lung Metastasis? An Evaluation using Genome-wide Microarray Analysis”" Virginia Surgical Society (2012)
"“S1P generated by SphK1 is important not only for primary tumor growth but also for tumor-induced hemangiogenesis and lymphangiogenesis”" The 103rd Annual Meeting American Association of Cancer Research (2012)
"“Sphingosine kinase 1-induced sphingosine-1-phosphate promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis”" The 8th Annual VCU Women’s Health Research Day (2012)
"“Surgical Resection of the Primary Tumor in Metastatic Breast Cancer Decreases Overall Tumor Burden and Improves Survival”" Virginia Surgical Society (2012)
"“Development of novel cancer cell implantation method to generate murine metastatic breast cancer model for translational research and drug development”" Women’s Health 2012: The 20th Annual Meeting (2012)
"“Genome-wide Microarray Analysis Demonstrates Significantly Different Tumor Gene Expression Profiles between Sites of 4T1 Cell Implantation”" 7th Annual Academic Surgical Congress (2012)
"“Primary Tumor Resection Decreased the number of Myleoid Deprived Suppressor Cells and Increased CD4 and CD8 Cells”" 7th Annual Academic Surgical Congress (2012)
"“Surgical Stress and Removal of Primary Lesion Influence Breast Cancer Progression, But Survival is determined by Overall Tumor Burden”" 7th Annual Academic Surgical Congress (2012)
"“Targeting breast cancer metastasis using FTY720”" 7th Annual Academic Surgical Congress (2012)
"“The Preclinical Development of FTY720, a Sphingosine-1-Phosphate Receptor Modulator, as a Novel Targeting Therapy against Breast Cancer”" 7th Annual Academic Surgical Congress (2012)
"General Surgery Training in the Untied States" 25th Mito Soushyouchiyu Danwakai" (2012)
"Practical Aspects of Postgraduate Education in the United States" Special Lecture at Nippon Medical School (2012)
"Obesity in the United States: role of Nutrition Support Team" Annual NST Lecture at Sanraku Hospital (2011)
"The role of sphingosine-1-phosphate (S1P) signaling pathway and bile acid in dies induced non-alcoholic fatty liver disease (NAFLD)" 21st World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists." (2011)
"“Cancer-induced angiogenesis and lymphangiogenesis are regulated by sphingosine kinase 1”" 2011 VCU Massey Cancer Center Research Retreat (2011)
"“Sphingosine-1-phosphate Axis as a Novel Target for Metastatic Breast Cancer by Suppression of Angiogenesis and Lymphangiogenesis”" Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Scholars Meeting; ; National Institute of Health (2011)
"“Suppression of breast cancer growth and metastatic disease using a novel therapy: FTY720”" 2011 VCU Massey Cancer Center Research Retreat (2011)
"“Breast cancer lymph node metastasis is mediated by sphingosine-1-phosphate”" The 7th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2011)
"“Breast cancer subtypes have different expression profiles of ATP-binding cassette transporters”" The 7th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2011)
"“Development of in vivo quantification of angiogenesis and lymphangiogenesis”" 28th Annual Daniel T. Watts Research Poster Symposium (2011)
"“Efficacy of FTY720 in the suppression of breast cancer and its lung metastasis”" The 7th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2011)
"“Expressions of ATP-binding cassette transporters varies among subtypes in breast cancer”" 28th Annual Daniel T. Watts Research Poster Symposium (2011)
"“FTY720 suppressed breast cancer lung metastasis using a 4T1-luc2 cell implantation model”" 28th Annual Daniel T. Watts Research Poster Symposium (2011)
"“Specific inhibitor of Sphingosine Kinase 1 suppresses tumor-induced angiogenesis and lymphangiogenesis”" The 97th Annual American College of Surgeons Clinical Congress (2011)
"“Triple negative breast cancer has high expressions of ATP-binding transporters, C1 and G2”" 2011 VCU Massey Cancer Center Research Retreat (2011)
"“FTY720 as a novel therapy against breast cancer progression by modulation of the Sphingosine-1-Phosphate receptor”" The 8th Annual VCUHS Resident Research Day at VCU (2011)
"“Sphingosine Kinase 1 generated Sphingosine-1-phosphate promotes breast cancer progression by tumor-induced angiogenesis and lymphangiogenesis”" Breast Cancer Research Interest Group Meeting at VCU (2011)
"“FTY720 as a novel Sphingosine-1-Phosphate receptor targeting therapy against breast cancer progression”" Department of Surgery Research Day, VCU (2011)
"“Genome‐wide Microarray Analysis Validates the Benefits of Orthotopic Breast Cancer Mouse Models for Translational Research in the Era of Targeted Therapy”" 2011 Annual Meeting of Virginia Surgical Society (2011)
"“Surgical Resection of the Primary Tumor in Metastatic Breast Cancer Decreases Overall Tumor Burden and Improves Survival”" Department of Surgery Research Day, VCU (2011)
"“Effect of sphingosine kinase 1 inhibition in validated syngeneic mouse breast cancer metastasis model”" The 102nd Annual Meeting American Association of Cancer Research (2011)
"“S1P produced by SphK1 is an important factor in breast cancer-induced angiogenesis/lymphangiogenesis”" The 7th Annual VCU Women’s Health Research Day (2011)
"“Surgical Resection of Primary Tumor in Metastatic Breast Cancer Reduces Overall Tumor Burden and Improves Survival”" The 7th Annual VCU Women’s Health Research Day (2011)
"“The Role of Sphingosine-1-phosphate (S1P) in Breast Cancer Progression and lymphangiogenesis" Breast Cancer Research Interest Group Meeting at Virginia Commonwealth University (2011)
"“Serum Sphingosine -1-Phosphate Level in Breast Cancer Mouse Model and Patients”" 64th Annual Cancer Symposium,; ; The Society of Surgical Oncology (2011)
"“Choosing The Right Translational Animal Model Matters: Subcutaneous Versus Orthotopic Implantation Of Mouse Breast Cancer Differentially Expresses Genes”" 6th Annual Academic Surgical Congress (2011)
"Role of Sphingosine-1-phosphate in cancer progression" Cell Signaling Retreat; ; VCU Massey Cancer Center Cancer (2010)
"“Are We Using the Appropriate Mouse Model to Study Breast Cancer Progression?”" 7th Annual Interdisciplinary Women’s Health Research Symposium (2010)
"“Elucidating the role of sphingosine kinase 1 in breast cancer progression using newly validated syngeneic mouse model”" The 45th Annual Southeastern Regional Lipid Conference (2010)
"“FTY720 Targeting metastatic breast cancer”" Massey Cancer Center 2010 Cancer Research Retreat (2010)
"“Isozyme-specific inhibitor of sphingosine kinase 1 inhibits breast cancer progression and tumor lymphangiogenesis”" Massey Cancer Center 2010 Cancer Research Retreat (2010)
"“Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription”" Massey Cancer Center 2010 Cancer Research Retreat (2010)
"“Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription”" 27th Annual Daniel T. Watts Research Poster Symposium (2010)
"“Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription”" The 6th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2010)
"“Role of Sphingosine-1-phosphate and Sphingosine kinase 1 in Cancer progression and cancer-induced lymphangiogenesis”" 27th Annual Daniel T. Watts Research Poster Symposium (2010)
"“Serum S1P levels in breast cancer mouse model and patients”" Massey Cancer Center 2010 Cancer Research Retreat (2010)
"“Sphingosine-1-phosphate induces lymphangiogenesis in syngeneic mouse breast cancer model”" The 6th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2010)
"“Why obesity is unhealthy”" 16th Medical Lecture for Japanese Society in Virginia, The Japan-Virginia Society (2010)
"Sphingosine-1-phosphate in breast cancer and associate lymphangiogenesis" VCU BIRCWH Scholar meeting (2010)
"“Mouse breast cancer model demonstrates survival benefit of mastectomy in metastatic breast cancer”" The 7th Annual VCUHS Resident Research Day at Virginia Commonwealth University (2010)
"Exon-based Clustering of Murine Breast Tumor Transcriptomes Demonstrates the Optimal Mouse Breast Cancer Metastasis Model for Translational Research" Department of Surgery Research Day; ; Virginia Commonwealth University (2010)
"“In A Metastatic Breast Cancer Mouse Model Mastectomy Improves Survival In Mice”" Department of Surgery Research Day, Virginia Commonwealth University (2010)
"Sphingosine Kinase 1 as a New Target to Treat Breast Cancer" The 6th Annual Women's Health Research Day at Virginia Commonwealth University (2010)
"“Resection of primary tumor improved survival in metastatic breast cancer in mouse model”" The 101th Annual Meeting American Association of Cancer Research (2010)
"“Resection of Primary Tumor Improves Survival in Mouse Metastatic Breast Cancer Model”" 2010 Annual Meeting of Virginia Surgical Society (2010)
"“Sphingosine Kinase 1 Mediates LPA-Induced Gastric Cancer Cell Proliferation”" The 101th Annual Meeting American Association of Cancer Research (2010)
"“Targeting Sphingosine Kinase 1 Is Promising Novel Strategy against Breast Cancer”" The 101th Annual Meeting American Association of Cancer Research (2010)
"“Sphingosine Kinase 1; a New Target against Breast Cancer”" 63rd Annual Cancer Symposium, the Society of Surgical Oncology (2010)
"Esophageal Cancer and Pancreatic Cancer" Q and A Session for Junior Surgical Residents in VCU program (2010)
"How to Prevent Common Cold" Lecture in Japanese for Richmond Branch of Japanese School (2010)
"Overview of the Link between SphK2/S1P2 and Liver" Sphingosine-1-phosphate, Liver and Bile Acids (Morning workshop) (2010)
"“Estradiol-Induced Sphingosine-1-Phosphate Is Released via ABCC1 and ABCG2, and Activates ERK1/2.”" 5th Annual Academic Surgical Congress, Association for Academic Surgery (2010)
"“Newly Found Liver Phenotype of SphK2 -/-" Sphingosine-1-phosphate, Liver and Bile Acids (Morning Workshop) (2010)
"“Non-Genomic ER-Alpha but Not GPR30 Is Involved in Estradiol-Mediated Release of Sphingosine-1-Phosphate from Breast Cancer.”" 5th Annual Academic Surgical Congress, Association for Academic Surgery (2010)
"Overview of the Link between SphK2/S1P2 and Liver" Liver and Bile Acids (2010)
"The Role of Sphingosine-1-phosphate (S1P) in Breast Cancer Progression and Drug Resistance" Breast Cancer Research Interest Group Meeting; ; Virginia Commonwealth University (2010)
"New Frontiers in the Management of Colorectal Cancer Liver Metastasis" 17th International Postgraduate Course, International Association of Surgeons, Gastroenterologists and Oncologists. (2009)
"“Estradiol-mediated export of sphingosine 1-phosphate from breast cancer cell is via non-genomic effect of estrogen receptor, and not GPR30”" Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Scholars Meeting; ; National Institute of Health (2009)
"“S1P export from breast cancer cells by ABCC1 and ABCG2 is stimulated by estradiol”" The 44th Annual Southeastern Regional Lipid Conference (2009)
"“Sphingosine Kinase 1 Regulates LPA-Induced Gastric Cancer Cell Proliferation”" The 44th Annual Southeastern Regional Lipid Conference (2009)
"“The Establishment of a Breast Cancer Model with Luminescent 4T1-luc2 cells to Investigate the Role of S1P in Cancer Progression, Metastasis and Treatment”" The 44th Annual Southeastern Regional Lipid Conference (2009)
"“E2-induced export of S1P from breast cancer cells mediated by ABC transporters”" The 7th Annual Undergraduate Research Symposium / 5th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat (2009)
"“Inside-Out Signaling Of Estradiol-Mediated S1p Export From Breast Cancer Cells”" 26th Annual Daniel T. Watts Research Poster Symposium (2009)
"“LPA-Induced Gastric Cancer Cell Proliferation Is Mediated By Sphingosine Kinase-1”" 26th Annual Daniel T. Watts Research Poster Symposium (2009)
"“Role of mastectomy in Stage IV breast cancer using newly established mouse metastatic breast cancer model" Breast Cancer Research Interest Group Meeting at Virginia Commonwealth University (2009)
"“Signaling pathway of LPA-induced cell proliferation in MKN gastric cancer cells”" The 7th Annual Undergraduate Research Symposium / 5th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat (2009)
"“The Application Of Luminescent In Vivo Imaging Using 4t1-Luc2 Cells To Determine The Best Model For Breast Cancer Progression And Metastasis”" 26th Annual Daniel T. Watts Research Poster Symposium (2009)
"“The Use of Luminescent 4T1-luc2 cells in a Murine Model for Breast Cancer Progression and Metastasis as a Translational Tool for Applying the Role of S1P in Cancer to Clinical Therapy”" The 7th Annual Undergraduate Research Symposium / 5th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat (2009)
"Systemic Therapy of Colon Cancer" 19th Worlld Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (2009)
"“Discovering How Research Helps Fight Breast Cancer”" Discovery Dialogues Seminar at Virginia Commonwealth University (2009)
"“The Establishment of Breast & Colon Cancer Metastasis, and Liver Regeneration Models in Rodents”" Biochemistry Departmental Retreat at Rice Center, Virginia Commonwealth University (2009)
"The Reality of American Medical Practice" ; Yokohama City University Graduate School of Medicine; Dean‘s Invited Lecture for Graduate Students (2009)
"“Estradiol Stimulates Rapid Production and Export of Sphingosine-1-Phosphate from Breast Cancer Cells via ATP-Binding Cassette Transporters”" The 5th Annual VCUHS Resident Research Day at Virginia Commonwealth University (2009)
"“E2 induces Export of Sphingosine-1-Phosphate from Human Breast Cancer MCF-7 Cells: Potential involvement in non-genomic effects” R" Biochemistry Rotation Talks at Virginia Commonwealth University (2009)
"“Estradiol stimulates export of sphingosine-1-phosphate from breast cancer cells by specific ABC transporters”" The 5th Annual Women’s Health Research Day at Virginia Commonwealth University (2009)
"“Estradiol stimulates export of sphingosine-1-phosphate from breast cancer cells by specific ABC transporters”" The 100th Annual Meeting of American Association of Cancer Research (2009)
"“Estradiol, but not EGF, Stimulates Rapid Production and Export of Sphingosine-1-Phosphate from Human Breast Cancer Cells”" Annual Meeting of Virginia Chapter of American College of Surgeon (2009)
"“Outcomes of a Hybrid Technique for Video-Assisted Thoracoscopic Surgery (VATS) Pulmonary Resection in a Community-Based Practice”" Annual Meeting of Society of American Gastrointestinal Endoscopic Surgeons (2009)
"“Outcomes of a Hybrid Technique for Video-Assisted Thoracoscopic Surgery (VATS)”" 56th Annual Meeting of Virginia Surgical Society (2009)
"“Rapid export of sphingosine-1-phosphate from breast cancer cells MCF-7 is mediated by estradiol and ABCC1 transporter”" Experimental Biology 2009; ; American Society for Biochemistry and Molecular Biology (2009)
"“Estradiol, but not Epidermal Growth Factor, Stimulates Rapid Production and Export of Sphingosine-1-Phosphate from Human Breast Cancer Cells”" ; ; 62th Annual Cancer Symposium, the Society of Surgical Oncology (2009)
"“Estradiol (E2) Induces Immediate Export of Sphingosine 1-phosphate (S1P) from Breast Cancer Cells by Specific ATP-Binding Cassette (ABC) Transporters”" Breast Cancer Research Interest Group Meeting at Virginia Commonwealth University (2009)
"“What is Coming Next on Treatment of Colon Cancer Liver Metastasis”" 16th International Postgraduate Course & 3rd Course of the International Society of Surgery and Oncology, International Association of Surgeons, Gastroenterologists and Oncologists (2008)
"“Estradiol Induces Export of Sphingosine-1-Phosphate from Human Breast Cancer Cells via ABC Transporters”" The 43rd Annual Southeastern Regional Lipid Conference (2008)
"“LC-MS/MS Determination of Sphingolipids in Cell Culture Media" The 43rd Annual Southeastern Regional Lipid Conference (2008)
"“The role of ABC transporter in export of sphingosine 1-phosphate from breast cancer cell”" Fifth Annual Interdisciplinary Women’s Health Research Symposium; Office of Women’s Health National Institute of Health (2008)
"“The role of ABC transporter in export of sphingosine 1-phosphate from breast cancer cell”" Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Scholars Meeting; ; National Institute of Health (2008)
"“Treatment of Breast Cancer: Japan vs. U.S.”" 15th Medical Lecture for Japanese Society in Virginia, the Japan-Virginia Society (2008)
"“Export of Sphingosine-1-phosphate from breast cancer cells occur via specific ABC transporters”" 25th Annual Daniel T. Watts Research Poster Symposium (2008)
"“p53 independent Synergistic Effect of Sphingosine Kinase-1 Inhibitor with Irinotecan on Colon Cancer Cell, HCT-116”" The 94th Annual American College of Surgeons Clinical Congress (2008)
"“Treatment of Breast Cancer: Japan vs. U.S.”" 14th Medical Lecture for Japanese Society in Virginia; ; the Japan-Virginia Society (2008)
"“ABC Transporters, ABCC1 and ABCG2, but not ABCB1 Export Sphingosine 1-Phosphate from Human Breast Cancer Cells”" The 4th Annual VCUHS Resident Research Day (2008)
"“Postgraduate Clinical Training in the U.S. and the Role of Clinicians in Basic Research”" ; Niigata University School of Medicine (2008)
"“Sphingosine-1-phosphate as a Signaling Molecule and its Relationship with Autophagy”" National Center for Child Health & Development (2008)
"“Inhibition of Sphingosine Kinase-1 Using SKI-1 Induce Autophagy”" Virginia Chapter of American College of Surgeons (2008)
"“ABC Transporters, ABCC1 and ABCG2, are Involved in Estradiol Induced Export of Sphingosine 1-Phosphate from Human Breast Cancer Cells”" The 99th Annual Meeting of American Association of Cancer Research (2008)
"“ABC Transporters, ABCC1 and ABCG2, Export Sphingosine 1-Phosphate from Human Breast Cancer Cells in Response to Estradiol”" The 4th Annual Women’s Health Research Day at Virginia Commonwealth University (2008)
"“Autophagy is induced by Sphingosine Kinase Inhibition by SKI-1”" The 25th Annual Seminar of Cancer Researchers in Virginia by American Cancer Society (2007)
"“Inhibition of Sphingosine Kinase-1 Using SKI-1 Induce Autophagy”" Virginia Chapter of American College of Surgeon Paper Competition (2007)
"“Sphingosine Kinase-1 Inhibition by SKI-1 Induce Autophagy”" The 3rd Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat (2007)
"“Advantage of undergoing surgery in the U.S.”" 13th Medical Lecture for Japanese Society in Virginia, the Japan-Virginia Society (2007)
"“Surgical Techniques to treat Breast Cancer”" Department of Radiation Oncology, Massey Cancer Center VCU (2007)
"“Serum Follistatin Levels Predict the Extent of Liver Regeneration after Hepatectomy”" Virginia Chapter of American College of Surgeons (2007)
"“Serum Follistatin Levels Immediately after Hepatectomy Predict the Extent of Liver Regeneration”" 2007 60th Annual Cancer Symposium, the Society of Surgical Oncology (2007)
"“Foley for Chole – One Option to avoid Laparoscopic Cholecystectomy Disaster”" 14th International Postgraduate Course of International Society of Surgery and Oncology, International Association of Oncology, International Association of surgeons, Gastroenterologists and Oncologists. (2006)
"“Serum Follistatin Levels Predict the Extent of Liver Regeneration after Hepatectomy”" Virginia Chapter of American College of Surgeon Paper Competition (2006)
"“Massive lower gastrointestinal bleeding in a patient newly diagnosed with human immunodeficiency virus”" Hunt Annual Meeting of American Gastroenterology Association (2006)
"“Postgraduate Training in the United States”" Grand Rounds - Department of Medicine; ; Toride Kyodo Hospital (2006)
"“Surgical Residency in the United States”" National Center for Child Health & Development (2006)
"“Hernia Sac Laparoscopy under Spinal Anesthesia for Evaluation of Reduced Incarcerated Inguinal Hernia”" Society of American Gastrointestinal Endoscopic Surgeons (2006)
"“The role of Activin and Follistatin in Liver Regeneration”" 9th Yujin Memorial Young Investigator Award Acceptance Lecture; Niigata University School of Medicine (2005)
"“Serum Follistatin Levels Predict the Extent of Liver Regeneration after Hepatectomy in Human and Rat Models”" Surgical Forum 2004 Clinical Congress, the American College of Surgeons (2004)
"“Activin Inhibits Liver Regeneration from Overgrowing”" Surgical Forum 2003 Clinical Congress, the American College of Surgeons (2003)
"“Effects of Massive Liver Removal on Serum Follistatin Levels" The 83rd Annual Meeting of the Endocrine Society (2003)
"“Sustained Elevation of Serum Follistatin Level as an Early Predictor of Post-hepatectomy Liver Failure”" San Diego Chapter of the American College of Surgeons and San Diego Society of General Surgeons Spring 2003 (2003)
"“Sustained Elevation of Serum Follistatin Level as an Early Predictor of Post-hepatectomy Liver Failure”" San Diego Chapter of the American College of Surgeons; ; San Diego Society of General Surgeons Spring 2003 (2003)
"Artificial Enlargement of the Liver by Suppression of Inhibitory Growth Factor, Activin - A Possible Measure to Solve Donor Liver Shortage-" San Diego Society of General Surgeons Meeting (2002)
"“Artificial Enlargement of the Liver by Suppression of Inhibitory Growth Factor, Activin –A Possible Measure to Solve Donor Liver Shortage –“" San Diego Society of General Surgeons Meeting (2002)
"“Serum Follistatin Level as an Early Detection Marker of Post-hepatectomy Liver Failure: Using Our Novel Rat 90% Hepatectomy Model”" Society for Surgery of Alimentary Tract, Digestive Disease Week 2001 (2001)
"“Adenovirus-mediated Overexpression of Follistatin Results in Enlargement of the Liver in Normal Adult Rats”" The Salk Poster Day (2001)
"“Adenovirus-mediated Overexpression of Follistatin Results in Enlargement of the Liver in Normal Adult Rats”" The 51st Annual Meeting of the American Association for the Study of Liver Diseases (2000)
"“Adenovirus-mediated Overexpression of Follistatin Enlarge the Intact Liver in Rats.”" The 82nd Annual Meeting of the Endocrine Society (2000)
"“Adenovirus-mediated Overexpression of Follistatin Enlarge the Intact Liver in Rats”" The 82nd Annual Meeting of the Endocrine Society (2000)
"“Why Cadaveric Transplantations are Rare in Japan”" ; ; University of California San Diego (2000)
"“Correction of Hemophilia B with Lentiviral Vectors.”" 2000 Keystone Symposia, Gene Therapy (2000)
"“Recombinant Adenovirus Vector Encoding Follistatin: A Potential Tool to Stimulate Liver Regeneration”" The 50th Annual Meeting of the American Association for the Study of Liver Diseases (1999)
"“Blockage of Endogenous Activin by Recombinant Adenovirus Vector Encoding Follistatin cDNA”" 1999 North American Inhibin and Activin Congress (1999)
"“Postgraduate Training in the United States”" ; ; Yoshida Scholarship Foundation (1999)
"“Expression of Activin in Hepatoma Cell Lines and Its Signal Transduction”" The 51st Meeting of Japanese Society of Gastroenterological Surgery (1999)
"“Two Cases of Duodenal Ulcer Perforation Retreated Conservatively Following Initial Conservative Therapy”" The 3rd Meeting of Akita Research Association of Conservative Therapy on Peptic Ulcer Perforation (1999)
"“Ligand-Dependent Association of Smad2 and Smad3 with the Activin Receptor Complex”" The 80th Annual Meeting of the Endocrine Society (1998)
"“Use of an Antisense Oligonucleotide Approach to Assess the Role of Activin as an Anti-Proliferative Agent in the Liver”" The 80th Annual Meeting of the Endocrine Society (1998)
"“Cell Growth Effect Using Activin A Antisense Oligonucleotide –Future Drug for Liver Regeneration–“" The 98th Annual Meeting of the Japan Surgical Society (1998)
"“Interaction of the Smad Proteins with the Activin Receptor Complex”" McGill University, Endocrine Retreat Program (1998)
"“Expression of Activin A and its Suppression During Liver Regeneration – Study using Activin A Antisense Oligo –“" The 10th Annual Meeting of Liver Regeneration Research Meeting (1997)
"“Possibility of Activin A Antisense as a Liver Regeneration Accelerator that Enables Extensive Hepatectomy”" The 9th Annual Meeting of Japanese Hepato-Biliary Pancreatic Surgery Society (1997)
"“Usefulness of Large Animal Models in Liver Transplantation Studies”" The 9th Annual Meeting of Japanese Hepato-Biliary Pancreatic Surgery Society (1997)
"A Case of StrangulatingIntestinal Obstruction Caused by Internal Hernia Due to a Parasite" The 42nd Annual Meeting of Kanagawa Gastroenterological Research Association (1997)
"“Activin A Antisense Oligonucleotides Accelerate Hepatic Cell Proliferation”" 1997 Annual Meeting during Digestive Disease Week (1997)
"“Activin A and its Antisense Oligonucleotide – As a Marker of Liver Regeneration and as an Accelerator –“" The 97th Annual Meeting of the Japan Surgical Society (1997)
"“Activin A Expression and Suppression during Liver Regeneration – Findings using Activin A Antisense Oligo”" The 83rd Annual Meeting during Digestive Disease Week - Japan 1997 (1997)
"“Evaluation of Transplanted Liver Viability Using Oxygen Saturation of Hepatic Venous Blood”" The 97th Annual Meeting of the Japan Surgical Society (1997)
"“Expression of Activin A mRNA After Hepatectomy – Can it be a Marker of Liver Regeneration?”" The 49th Meeting of Japanese Society of Gastroenterological Surgery (1997)
"“Activin A Antisense Oligonucleotides Accelerate Hepatocyte Proliferation”" International Conference on Inhibin, Activin, Follistatin (1996)
"“Importance of Serum-MMP2 and 9 Expression as Markers of Colon Cancer”" The 34th Annual Meeting of Japanese Association of Cancer Treatment (1996)
"“Analysis of Hemodynamics During Reperfusion in Liver Transplantation”" The 32nd Annual Meeting of the Japan Transplantation Society (1996)
"“Study of Minimum Requirement of the Liver and Its Regeneration in Partial Liver Transplantation”" The 32nd Annual Meeting of the Japan Transplantation Society (1996)
"Study of Minimum Requirement of the Liver in Partial Liver Transplantation" The 14th Annual Meeting of Liver Transplantation Research Group (1996)
"“Postreperfusion Syndrome in Liver Transplantation”" The 14th Annual Meeting of Liver Transplantation Research Group (1996)
"Mechanism of Worsening of Postoperative Sepsis and Its /treatnebt" The 21st Meeting of United Surgical Association of Japan (1996)
"Postreperfusion Syndrome in Liver Transplantation" The 8th Annual Meeting of Kanagawa Transplantation Research Group. (1996)
"“Study of Minimum Requirement of the Liver in Partial Liver Transplantation”" The 96th Annual Meeting of the Japan Surgical Society (1996)
"“Complications and Their Treatments of Laparoscopic Cholecystectomy”" The 47th Meeting of Japanese Society of Gastroenterological Surgery (1996)
"A Case of Megacolon Complicated with Adrenal Hemochromocytoma" The 237th Meeting of Japanese Society of Gastroenterology; ; Kanto Division (1995)
"“Diagnosis and Treatment of Postoperative Intra-abdominal Infections”" The 8th Annual Meeting of Japanese Surgical Infection Research Association (1995)
"A Case of Salmonella Enteritis that Caused Acte Circulatory Failure after Breast Cancer Chemotherapy" The 83rd Meeting of Kanagawa Clinical Surgery Society (1995)
"Complication and its Treatment of Laparoscopic Cholecystectomy" The 2nd Meeting of Kanagawa Postoperative Metabolism and Nutrition Research Group (1995)
"Outcome of the Treatment of Thyroid Cancer Recurrence" The 31st Meeting of Akita Clinical Surgery Meeting (1995)
"Usefulness of Gastrostomy in Postoperative Care" The 30th Meeting of Akita Clinical Surgery Meeting (1994)

See all (334 more)

Service Activities:

Journal of Surgical Research JSR-16-01609; Ad Hoc Reviewer (2017–present)
Journal of Surgical Research JSR-16-01674; Ad Hoc Reviewer (2017–present)
Journal of Surgical Research JSR-16-01688; Ad Hoc Reviewer (2017–present)
Scientific Reports SREP-16-47536; Ad Hoc Reviewer (2016–present)
Journal of Surgical Research JSR-16-01605; Ad Hoc Reviewer (2016–present)
BMC Cancer BCAN-D-16-01043; Ad Hoc Reviewer (2016–present)
International Journal of Molecular Sciences ijms-164049; Ad Hoc Reviewer (2016–present)
BMC Research Notes RESN-D-16-01255; Ad Hoc Reviewer (2016–present)
Journal of Surgical Research JSR-16-01092; Ad Hoc Reviewer (2016–present)
Journal of Surgical Research JSR-15-01652; Ad Hoc Reviewer (2016–present)
Surgery (16-SUS-104); Ad Hoc Reviewer (2016–present)
Surgery (16-SUS-115); Ad Hoc Reviewer (2016–present)
Surgery (16-SUS-132); Ad Hoc Reviewer (2016–present)
Surgery (16-SUS-146); Ad Hoc Reviewer (2016–present)
Surgery (16-SUS-176); Ad Hoc Reviewer (2016–present)
Surgery (16-SUS-78); Ad Hoc Reviewer (2016–present)
Surgery (16-SUS-96); Ad Hoc Reviewer (2016–present)
Oncotarget (#15084); Ad Hoc Reviewer (2016–present)
Society of University Surgeons (2016–present)
Journal of Surgical Research (JSR-16-00143); Ad Hoc Reviewer (2016–present)
Journal of Surgical Research (JSR-16-00143); Ad Hoc Reviewer (2016–present)
Journal of Surgical Research (JSR-16-00205); Ad Hoc Reviewer (2016–present)
Journal of Surgical Research (JSR-16-00222); Ad Hoc Reviewer (2016–present)
Science Signaling (aaf3241); Ad Hoc Reviewer (2016–present)
Professional Service Society of University Surgeons; Committee Member (2016–2018)
Journal of Surgical Research (JSR-15-01675); Ad Hoc Reviewer (2016–present)
Journal of Surgical Research (JSR-15-01652); Ad Hoc Reviewer (2015–present)
Journal of Surgical Research (JSR-15-01654); Ad Hoc Reviewer (2015–present)
Oncotarget (#009951); Ad Hoc Reviewer (2015–present)
International Journal of Cancer (IJC-15-2122); Ad Hoc Reviewer (2015–present)
Clinical Cancer Research (155717); Ad Hoc Reviewer (2015–present)
International Journal of Cancer (IJC-15-1546); Ad Hoc Reviewer (2015–present)
Mediators of Inflammation (MI-854875); Ad Hoc Reviewer (2015–present)
Surgery Today (ST-2015-0330-RA); Ad Hoc Reviewer (2015–present)
American Society for Clinical Oncology; Member (2015–present)
World Journal of Gastroenterology (ESPS-17138); Ad Hoc Reviewer (2015–present)
Experimental Cell Research (ECR-15-261); Ad Hoc Reviewer (2015–present)
Edorium Journal of Surgery; Editor-In-Chief (2015–present)
BoneKey (Bonekey-14-01970A); Ad Hoc Reviewer (2015–present)
International Journal of Cancer (IJC-15-0583); Ad Hoc Reviewer (2015–present)
Association for Academic Surgery (2015–present)
BMC Cancer (4435223051587742); Ad Hoc Reviewer (2015–present)
Professional Service Association for Academic Surgery Publication Committee Member; Committee Member (2015–2017)
Professional Service American Society of Clinical Oncology; Committee Member (2015–present)
Professional Service Edorium Journal of Surgery; Editor-In-Chief (2015–present)
Pancreatology (PAN-D-14-00247R1); Ad Hoc Reviewer (2014–present)
Lipids (Lipids-14-0211); Ad Hoc Reviewer (2014–present)
Journal of Surgical Oncology (JSO-2014-0733); Ad Hoc Reviewer (2014–present)
Annal's of Surgery (ANNSURG-D-14-01242); Ad Hoc Reviewer (2014–present)
Annals of Surgical Oncology (ASO-2014-04-067); Ad Hoc Reviewer (2014–present)
Cancer Research (CAN-14-1131); Ad Hoc Reviewer (2014–present)
Journal of Biomedical Optics (JBO 140174SS); Ad Hoc Reviewer (2014–present)
British Journal of Cancer (MD/2014/3174); Ad Hoc Reviewer (2014–present)
Journal of Hepato-Biliary-Pancreatic Sciences (JHBP-D-14-00016); Ad Hoc Reviewer (2014–present)
Journal of American College of Surgeons (JACS-2013-1712); Ad Hoc Reviewer (2014–present)
Researchpub Organization Committee (2014–present)
British Journal of Cancer (MD/2013/3894); Ad Hoc Reviewer (2014–present)
Journal of Surgical Research (JSR-14-00103); Ad Hoc Reviewer (2014–present)
Journal of Surgical Research (JSR-14-00103); Ad Hoc Reviewer (2014–present)
Gland Surgery; Associate Editor (2014–present)
Service to the Department Department of Surgery Research Task Force; Co-Director (2014–present)
Journal of Surgical Research (JSR-13-01752); Ad Hoc Reviewer (2013–present)
Journal of Surgical Research (JSR-13-01613); Ad Hoc Reviewer (2013–present)
Annal of Surgical Oncology (ASO-2013-10-1558R1); Ad Hoc Reviewer (2013–present)
Annals of Surgical Oncology (ASO-2013-10-1558); Ad Hoc Reviewer (2013–present)
World Journal of Gastrointestinal Surgery (WJGS 6347); Ad Hoc Reviewer (2013–present)
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB/2013/302566); Ad Hoc Reviewer (2013–present)
Clinical Cancer Research (CCR-13-0081R1); Ad Hoc Reviewer (2013–present)
Journal of Surgical Oncology (JSO-2013-0584); Ad Hoc Reviewer (2013–present)
Future Oncology (2013-08-09); Ad Hoc Reviewer (2013–present)
Journal of Surgery and Science; Editor-In-Chief (2013–present)
Journal of Oncopathology (JOP-00005-2013-01); Ad Hoc Reviewer (2013–present)
Journal of Surgical Research (JSURGRES-D-13-00846); Ad Hoc Reviewer (2013–present)
Journal of Surgical Research (JSURGRES-D-13-00960); Ad Hoc Reviewer (2013–present)
World Journal of Surgical Oncology (1061921291870127); Ad Hoc Reviewer (2013–present)
Clinical Cancer Research (CCR-13-0081R); Ad Hoc Reviewer (2013–present)
Annals of Surgical Oncology (ADO- 2013- 04- 0616); Ad Hoc Reviewer (2013–present)
Biomolecules (32090); Ad Hoc Reviewer (2013–present)
Journal of Surgical Research (JSURGRES-D-13-00331); Ad Hoc Reviewer (2013–present)
Biomolecules; Editorial Board Member (2013–present)
Edorium Journal of Surgery; Editor (2013–2015)
Association for Academic Surgery, Global Affairs Committee (2013–2015)
JAMA Surgery (SUR13-0247); Ad Hoc Reviewer (2013–present)
Service to Profession Global Affairs Committee Member Association for Academic Surgery; Committee Member (2013–2015)
Hepatogastroenterology Surgical Oncology Section; Co-Editor and Author (2013–2014)
Professional Service Southeast Regional Lipid Conference; President (2013–2014)
Surgical Innovation (SRI-12-0193); Ad Hoc Reviewer (2013–present)
Journal of Hepato-Biliary-Pancreatic Sciences (JHBP-D-12-00304R1); Ad Hoc Reviewer (2013–present)
Journal of Surgical Research (JSR D12-00865R1); Ad Hoc Reviewer (2013–present)
Clinical Cancer Research (CCR-13-0081); Ad Hoc Reviewer (2013–present)
Service to Profession Journal of Surgery and Science; Editor-In-Chief (2013–present)
Journal of Surgical Research (JSR D12-00865); Ad Hoc Reviewer (2012–present)
Journal of Hepato-Biliary-Pancreatic Sciences (JHBP-D-12-003004); Ad Hoc Reviewer (2012–present)
Journal of Thoracic Disease; Associate Editor (2012–present)
Journal of Medical Case Reports (2012 5251206917949994); Ad Hoc Reviewer (2012–present)
Gastroenterology Research and Practice (150801 v1); Ad Hoc Reviewer (2012–present)
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB/2012/300384R1); Ad Hoc Reviewer (2012–present)
Gastroenterology Research and Practice (524180); Ad Hoc Reviewer (2012–present)
Journal of Cancer Therapy (8901394); Ad Hoc Reviewer (2012–present)
Journal of Surgical Research (JSR D12-00843); Ad Hoc Reviewer (2012–present)
Cancer Cell International (1067868202729754); Ad Hoc Reviewer (2012–present)
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB/2012/300384); Ad Hoc Reviewer (2012–present)
Gland Surgery; Editorial Board Member (2012–2013)
Human Pathology (YHUPA-D-12-00340); Ad Hoc Reviewer (2012–present)
Gastroenterology Research and Practice (529782.v1); Ad Hoc Reviewer (2012–present)
Journal of Surgical Research (D12-00330); Ad Hoc Reviewer (2012–present)
Molecular Oncology (MOLONC-D-12-00025R1); Ad Hoc Reviewer (2012–present)
Thoracic Center (TCA-CR-04-2012-0215); Ad Hoc Reviewer (2012–present)
PLoS ONE Academic Editor; Editor (2012–present)
Molecular Oncology (MOLONC-D-12-00025); Ad Hoc Reviewer (2012–present)
Archives of Surgery (SUR12-0148); Ad Hoc Reviewer (2012–present)
Service to the Institution Alternate University Faculty Senate (2012–2014)
Surgical Endoscopy (SEND-11-1265); Ad Hoc Reviewer (2011–present)
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB/2011/239970); Ad Hoc Reviewer (2011–present)
Journal of Surgical Research (JSR D11-00790); Ad Hoc Reviewer (2011–present)
Hepatogastroenterology; Editorial Board Member (2011–2012)
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB/2011/231662); Ad Hoc Reviewer (2011–present)
Association for Academic Surgery (2011–2013)
BMC Cancer (1801198568499379); Ad Hoc Reviewer (2011–present)
Annals of Surgery (ANNSURG-D-11-00027); Ad Hoc Reviewer (2011–present)
Service to Profession Association for Academic Surgery; Committee Member (2011–2013)
Service to the Institution Alternate IRB committee member (2011–2012)
Service to Community Principal of Richmond Saturday Japanese School (volunteer faculty) Principal was responsible for managing the organization of the school including teachers to conduct Japanese education in Richmond, VA; Principal (2011–2012)
ACOSOG (American College of Surgeons Oncology Group (2011–present)
Surgical Endoscopy (SEND-10-1598); Ad Hoc Reviewer (2011–present)
Service to Profession NSABP (National Surgical Adjuvant Breast and Bowel Project); Member (2011–present)
NSABP (National Surgical Adjuvant Breast and Bowel Project; Member (2011–present)
Surgical Endoscopy (SEND-10-1357); Ad Hoc Reviewer (2010–present)
Service to Profession Session Modulator, South Eastern Regional Lipid Conference (2010–present)
Journal of Thoracic Disease; Editorial Board Member (2010–2012)
Nature Reader Advisory Panel: NK2328905-51 (2010–2011)
Global Journal of Surgery; Editorial Board Member (2010–2011)
45th South Eastern Regional Lipid Conference; Member (2009–2010)
Service to Profession Noguchi Summer Medical School Kameda General Hospital, Chiba, Japan; Visiting Professor (2009)
Annals of Surgical Oncology (2009-07-0845); Ad Hoc Reviewer (2009–present)
Annals of Surgical Oncology (2009-07-0845); Ad Hoc Reviewer (2009–present)
Journal of American College of Surgery (; Ad Hoc Reviewer (2009–present)
Service to Profession South Eastern Regional Lipid Conference; Committee Member (2009–2011)
International Postgraduate School of the International Association of Surgeons Gastroenterologists and Oncologists (2009–present)
Service to Profession Editorial Board on World Journal of Gastroenterology; Hepatogastoenterology, Journal of Thoracic Disease and Gland Surgery. Academic Editor of the journal, , PLoS ONE; Editorial Board Member (2009–present)
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques; Ad Hoc Reviewer (2008–present)
Annals of Surgical Oncology (2008-03-0303); Ad Hoc Reviewer (2008–present)
Inpatient Service Ward Attending, average 3-10 dyas (2008–present)
Clinical - Outpatient Service Private outpatient Clinic at VCU Medical Center (2008–present)
Clinical Service - Outpatient Indulgent + Inmate Clinic at VCU Medical Center (2008–present)
Clinical Service,Out Outpatient Surgery at VCU Medical Center (2008–present)
Inpatient Service Consult Attending, Ave. 7 days per month; Consultant (2008–present)
Developmental Therapeutics Group; Member (2008–present)
Cancer Cell Signaling Group; Member (2008–present)
Advisor Educational Commission for Foreign Medical Graduates (ECFMG); Advisor (2007–present)
Service to Profession International Medical Graduates Advisors Network Educational Commission for Foreign Medical Graduates (ECFMG); Advisor (2007–present)
Service to Profession International Association of Surgeons, Gastroenterologists and Oncologists (Permanent Faculty); Visiting Professor (2006–present)
Service to Profession Member of Research/Education Committee American Hepato-Pancreato-Biliary Association; Committee Member (2003–2007)
American Hepato-Pancreato-Biliary Association; Member (2003–2007)
The Lancet; Ad Hoc Reviewer (2000–present)
Service to Profession Society of Research Fellows Committee Member The Salk Institute for Biological Studies; Committee Member (1999–2001)
The Salk Institute for Biological Studies; Member (1999–2001)
Cytokine; Ad Hoc Reviewer (1999–present)
Journal of Molecular and Genetic Medicine; Ad Hoc Reviewer (1999–present)
Alcohol Health & Research World; Ad Hoc Reviewer (1998–present)
Interviewer for Recruit Candidate Interview, Emmanuel Gabriel, MD, Roswell Park Cancer Institute
Recruit Interview Interview for candidate, Dr. Megan Kruse from the Cleveland Clinic (Medical Oncology)
Service to School/University/Institution Thanksgiving Reception for Staff Partners, Alliance foundation of RPCI (45 Lincolin Pkwy, Buffalo)
Service to School/University/Institution Reception for Dr. Reubin Harris, a guest scientist from HHMI/U MN (RPCI0
Host for Visiting Professor Host for Dr. Masayuki Nagahashi, Grand Rounds speaker for Roswell Park Cancer Institute
Service to the Institution/Univ./School Visit from Cayuga Medical Center at Ithaca (RPCI); Participant
Service to Institution Writing Winning Grant Proposals, Grant Writers' Seminar, Lauren Broyles (RPCI)
Service to the Institution Press Conference on CIMAvax Announcement (RPCI)
Postdoc Candidate Interview Maiko & Ichiro Okano MD, PhD @ Tokyo, Japan
Postdoc Candidate Interview Saeko Teraoka, MD @ Shinjuku, Japan
Service to the Institution Presentation on Breast Cancer Care at RPCI Amberleigh Retirement Community (Williamsville, NY); Presenter
Postdoc Candidate Interview Masaaki Yamamoto MD, PhD, Univ. Osaka (online)
Service to Institution ARTrageous affair Breast Cancer Gala Beast Cancer Colition of Rochester (Holiday Inn Rochester Downtown)
Service to Institution Pegula Sports & Entertainment visit (RPCI)
Service to the Institution BNMC Translational Genomics and Epigenomics Symposium Buffalo Niagara Medical Complex (RPCI)
Interview of Recruit Interview of Dr. Meeghan Lautner, University of Texas, San Antonio
Service to the Institution Cancer Stem Cell Conference 2016 Case Western Reserve University (Cleveland, OH); Participant
Service to the Institution Great Lakes Breast Cancer Symposium, University of Pittsburgh Cancer Institute, Cancer Pavilion (UPMC, PA); Participant
Service to the Institution 2016 AAMC Grant Writers Coaching Group for NIH Awards American Association of Medical Colleges (San Antonio, Tx); Participant
Service to the Institution Summit for Perfusion Imaging and Excellence in Surgery (sSPIES) 2016 NOVADAQ (Las Vegas, NV); Participant
Service to the Institution Presentation on Vision of RPCI Breast Surgery Division Buffalo Sabres Alumni Luncheon (RPCI); Presenter
Service to the Institution 2016 Breast Cancer Motorcycle Ride, Hosted by Governor Andrew Cuomo (Canalside); Participant
Service for the Institution Cancer Moonshot Summit with Vice President Joe Biden (RPCI); Participant
Service to the Institution RPCI participation in New York State Patient Navigation in Breast Cancer Screening Program (on line); Presenter
Service to the Institution Nipple Sparing Mastectomy: A Team Approach, Medtronic hands-on session (Rosemont, IL); Presenter
Recruit Interview Interviewed Dr. Lei Zheng, PhD from Johns Hopkins University (Path)
Service to the Department VCU Department of Surgery Research Day; Judge
Postdoc Candidate Interview Tsutomu Kawaguchi MD PhD @ Chicago, ACS
Recruit Interview Interview of candidate, Dr. Jia Fang from H.Lee Moffitt Cancer Center
Service to Community Medical Seminar for Japanese in Virginia; "What is wrong being fat?" Japan-Virginia Society (Newport News, VA); Guest Lecturer
Recruit Interview Interview of Jennifer Richer, PhD, candidate from Univ. of Colorado Anschutz (Path)
Postdoc Candidate Interview Ryousuke Ogura MD PhD @ VCU
Host for Visiting Professor Host for Dr. Takashi Ishikawa, Grand Rounds Speaker, Tokyo Medical University
Recruit Interview Interview of candidate, Dr. Hallgeir Rui from the Thomas Jefferson University (Path)
Recruit Interview Interview candidate, Dr. Abe DeAnda from NYU-Langone, MC (CT Surg)
Service to the Institution Establishment of medical student visiting/observation program with Tokyo Medical Univ(Organization of courtesy visit by TMU Leadership 4/23/2015)ersity, Japan
Service to the Institution PhD student interview, Urszula Warncke for Cancer and Molecular Medicine concentration in the Clinical and Translational Science program
Service to the Institution Poster Judge, 12th Annual VCUHS Resident/Fellow Research Day; Judge
Service to the Department VCU Department of Surgery Research Day; Judge
Service to the Institution Modulator/Mentor (Research 4 Residents and Fellows Series, Office of Graduate Education); Participant
Service to the Department Presenter of Research Award at the Bigger Dinner, VCU Surgery; Presenter
Postdoc Candidate Interview Eriko Katsuta MD PhD @ Tokyo, Japan (online)
Postdoc Candidate Interview Hiroaki Aoki MD PhD @ VCU
Postdoc Candidate Interview Masayo Aoki MD PhD @ Tokyo, Japan
Postdoc Candidate Interview Partha Mukhopadhyay PhD @ Omaha, Nebraska (online)
Service to the Institution Accreditation Council for Graduate Medical Education (ACGME) Clinical Learning Environment Review (CLER) visit Division Representative
Service to the Institution Faculty Search Committee member (Director of Lipidomics Core)
Service to the Institution Modulator (Research 4 Residents and Fellows Series, Office of Graduate Education)
Service to the Institution General Surgery Residency Program Evaluation Committee (PEC) member
Service to the Institution Tissue & Data Acquisition & Analysis Core (TDAAC) Policies and Utilization Review Committee member
Host for Visiting Professor Host for Dr. Waddah Al-Refaie, speaker at Grand Rounds, Georgetown University.
Service to the Institution Surgical Oncology Fellowship Program Evaluation Committee member; Committee Member
Service to the Institution Lecturer (BIOL410 Cancer Biology Course); Guest Lecturer
Service to the Department VCU Department of Surgery Research Day; Judge
Service to Community Invited Lecture at Saturday Enrichment Program for Gifted Learners, Center for Gifted Education, College of William and Mary (Richmond, VA); Guest Lecturer
Postdoc Candidate Interview Takayuki Tanaka MD @ Nagasaki, Japan
Postdoc Candidate Interview Kumiko Kida MD @ Yokohama, Japan
Postdoc Candidate Interview Tomoyoshi Aoyagi MD PhD @ Shinjuku, Japan
Recruit Interview Interview of Dr. Prateek Bhatia, PhD from Johns Hopkins University (Biochem)
Postdoc Candidate Interview Akimitsu Yamada MD @ Orlando, FL AACR
Host to Professor Host to Dr. Itaru Endo, Grand Rounds speaker at Yokohama City University.
Service to Community Medical Seminar for Japanese in Virginia; “What is wrong being fat?” Japan-Virginia Society (Newport News, VA); Participant
Service to Community Invited Lecture at Richmond Saturday Japanese School; Guest Lecturer
Service to the Community Discovery Dialogue "Discovering How Research Helps Fight Breast Cancer" Discovery Dialogue is a lecture series held by VCU junior faculty volunteers for lay audience visiting VCU Medical Center. This presentation was evaluated as 4.6 out of 5 by the audience attended.; Presenter
Recruit Interview Interview of Dr. Sasanka Ramanadham, PhD from Washington University
Recruiting Interview Interviewing of Jozef Dulak PhD, Jagiallonian University in Krakow Poland
Recruit Interview Interviewing of Takuya Sakaguchi, PhD, from University of California, San Francisco
Recruiting Interview Interviewing of Chien Li PhD, from the University of Virginia
Postdoc Candidate Interview Subramaniam "Subu" Ramachandran PhD @ DC, BIRCWH
Service to Community Medical Seminar for Japanese in Virginia; "Treatment of Breast Cancer; Japan vs. U.S." Japan-Virginia Society (Richmond, VA); Participant
Recruiting Interview Interviewing of Anton Wellstein, MD, PhD, from Georgetown University
Service to Community Medical Seminar for Japanese in Virginia; “Treatment of Breast Cancer: Japan vs. U.S.” Japan-Virginia Society (Richmond, VA); Participant
Postdoc Candidate Interview Masaki Nagaya MD, PhD @VCU
Postdoc Candidate Interview Masayuki Nagahashi MD, PhD @ Niigata, Japan
Recruiting Interview Interviewing of Keith Baker, PhD from the University of Utah
Recruiting Interview Interviewing candidate Xianlin Han PhD from Washington University
Recruiting Interview Interviewing of Martin G. Pomper, MD from Johns Hopkins University
SSO Surgical Oncology Fellow Candidate Interview One day interviews of surgical oncology fellow candidates, 2 times a year. One day ranking meeting to rank the candidates for the match.
General Surgery Residency Candidate Interaction/Interview Two days interaction and interviews of intern candidates, 3 times a year. One day reception for incoming interns.
Service to Public Medical Seminar for Japanese in Virginia; “Advantage of undergoing surgery in the U.S.” Japan-Virginia Society (Newport News, VA); Participant
Service to Institution Presentation Coaching Session by Stephanie Barnard (RPCI)

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

scroll-out

Contact Information

Surg Roswell Park Cancer Institute
Elm & Carlton St.
Buffalo, New York 14263
Phone: 716-845-5540
Fax: 716-845-5705
kazuakit@buffalo.edu

View map

Jacobs School of Medicine
and Biomedical Sciences

Kazuaki Takabe MD, PhD, FACS

Kazuaki Takabe
MD, PhD, FACS

Education and Training:

Employment:

Awards and Honors:

Grants and Sponsored Research:

Journal Articles:

Abstracts:

Professional Memberships:

Presentations:

Service Activities:

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

Jacobs School of Medicine and Biomedical Sciences

Join the School

Get Involved

Find People

UB Academic Health Center

Connect with Us

About The School

Centers and Affiliations

Education and Training

Research Facilities and Services

Health Care

Resources by Audience

Alumni and Friends

Governance

Learning Resources

Support Services

Site Tools

Jacobs School of Medicine and Biomedical Sciences

Jacobs School of Medicineand Biomedical Sciences

Kazuaki Takabe MD, PhD, FACS

Kazuaki Takabe MD, PhD, FACS

Education and Training:

Employment:

Awards and Honors:

Grants and Sponsored Research:

Journal Articles:

Abstracts:

Professional Memberships:

Presentations:

Service Activities:

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

Jacobs School of Medicine and Biomedical Sciences

Join the School

Get Involved

Find People

UB Academic Health Center

Connect with Us

About The School

Centers and Affiliations

Education and Training

Research Facilities and Services

Health Care

Resources by Audience

Alumni and Friends

Governance

Learning Resources

Support Services

Site Tools

Jacobs School of Medicine and Biomedical Sciences

Jacobs School of Medicine
and Biomedical Sciences

Kazuaki Takabe
MD, PhD, FACS